Second Report on Human Biomonitoring of Environmental Chemicals in Canada - Tables 13.1.1 to 15.12.6

F = Data is too unreliable to be published.

x = Suppressed to meet the confidentiality requirements of the Statistics Act.

E = Use data with caution.

Table 13.1.1: Perfluorobutanoic acid (PFBA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c1 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c1 footnotes

Table c1 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c1 footnote a referrer

Total, 12-79 years
2 1524 99.67 -- <LOD <LOD <LOD <LOD
12-19 years
2 507 99.41 -- <LOD <LOD <LOD <LOD
20-39 years
2 362 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 334 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 321 99.38 -- <LOD <LOD <LOD <LOD
 
Table 13.1.2: Perfluorobutanoic acid (PFBA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c2 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c2 footnotes

Table c2 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c2 footnote a referrer

Males, Total 12-79 years
2 765 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 254 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 170 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 176 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 165 100 -- <LOD <LOD <LOD X
Females, Total 12-79 years
2 759 99.34 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 253 98.81 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 192 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 158 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 156 98.72 -- <LOD <LOD <LOD X
 
Table 13.2.1: Perfluorohexanoic acid (PFHxA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c3 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c3 footnotes

Table c3 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c3 footnote a referrer

Total, 12-79 years
2 1524 98.10 -- <LOD <LOD <LOD <LOD
12-19 years
2 507 98.22 -- <LOD <LOD <LOD <LOD
20-39 years
2 362 98.07 -- <LOD <LOD <LOD <LOD
40-59 years
2 334 98.20 -- <LOD <LOD <LOD <LOD
60-79 years
2 321 97.82 -- <LOD <LOD <LOD <LOD
 
Table 13.2.2: Perfluorohexanoic acid (PFHxA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c4 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c4 footnotes

Table c4 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c4 footnote a referrer

Males, Total 12-79 years
2 765 98.30 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 254 99.21 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 170 98.24 -- <LOD <LOD <LOD X
Males, 40-59 years
2 176 97.16 -- <LOD <LOD <LOD X
Males, 60-79 years
2 165 98.18 -- <LOD <LOD <LOD X
Females, Total 12-79 years
2 759 97.89 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 253 97.23 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 192 97.92 -- <LOD <LOD <LOD X
Females, 40-59 years
2 158 99.37 -- <LOD <LOD <LOD X
Females, 60-79 years
2 156 97.44 -- <LOD <LOD <LOD X
 
Table 13.3.1: Perfluorooctanoic acid (PFOA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 20-79 years Table c5 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c5 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c5 footnotes

Table c5 footnote 1

For the purpose of total population comparisons, only values from participants aged 20-79 years were included as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c5 footnote a referrer

Table c5 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c5 footnote b referrer

Total, 20-79 years
1 2880 1.11 2.5
(2.4 - 2.7)
1.3
(1.1 - 1.4)
2.6
(2.4 - 2.8)
3.6
(3.4 - 3.8)
5.5
(5.1 - 5.8)
2 1017 0 2.3
(2.1 - 2.5)
1.1
(0.91 - 1.2)
2.4
(2.1 - 2.6)
3.3
(2.9 - 3.7)
5.3
(3.9 - 6.7)
Males, 20-79 years
1 1376 0.51 2.9
(2.7 - 3.2)
1.6
(1.4 - 1.7)
3.1
(2.8 - 3.3)
4.0
(3.7 - 4.3)
5.9
(5.4 - 6.4)
2 511 0 2.6
(2.4 - 2.9)
1.3
(0.99 - 1.6)
2.7
(2.5 - 2.9)
3.5
(3.2 - 3.9)
6.0
(4.3 - 7.7)
Females, 20-79 years
1 1504 1.66 2.2
(2.0 - 2.4)
1.0
(0.92 - 1.2)
2.2
(2.1 - 2.4)
3.1
(2.9 - 3.3)
5.0
(4.4 - 5.5)
2 506 0 2.0
(1.8 - 2.2)
0.92
(0.73 - 1.1)
2.0
(1.7 - 2.3)
2.9
(2.2 - 3.5)
4.4
(3.8 - 5.1)
 
Table 13.3.2: Perfluorooctanoic acid (PFOA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and Cycle 2 (2009-2011).
Cycle N %<LODTable c6 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c6 footnotes

Table c6 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c6 footnote a referrer

Table c6 footnote 2

Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c6 footnote b referrer

Total, 12-79 years
1Table c6 footnote b . . . . . . .
2 1524 0 2.3
(2.1 - 2.5)
1.1
(0.93 - 1.2)
2.3
(2.1 - 2.5)
3.2
(2.8 - 3.6)
5.0
(3.6 - 6.4)
12-19 years
1Table c6 footnote b . . . . . . .
2 507 0 2.1
(1.9 - 2.3)
1.2
(1.0 - 1.4)
2.1
(1.9 - 2.3)
2.6
(2.4 - 2.8)
4.1
(3.6 - 4.5)
20-39 years
1 979 1.12 2.4
(2.2 - 2.7)
1.1
(0.95 - 1.3)
2.5
(2.3 - 2.8)
3.6
(3.3 - 3.8)
5.4
(4.8 - 5.9)
2 362 0 2.2
(1.9 - 2.5)
0.88
(0.64 - 1.1)
2.3
(1.9 - 2.8)
3.2
(2.8 - 3.7)
5.8
(3.9 - 7.6)
40-59 years
1 983 1.02 2.5
(2.3 - 2.7)
1.3
(1.2 - 1.4)
2.5
(2.3 - 2.8)
3.5
(3.2 - 3.7)
5.4
(4.6 - 6.1)
2 334 0 2.2
(2.0 - 2.4)
1.1
(0.87 - 1.3)
2.1
(1.7 - 2.5)
3.1
(2.7 - 3.6)
4.4
(3.9 - 5.0)
60-79 years
1 918 1.20 2.8
(2.5 - 3.0)
1.5
(1.3 - 1.7)
2.8
(2.6 - 3.0)
3.9
(3.5 - 4.4)
6.3
(5.4 - 7.1)
2 321 0 2.8
(2.4 - 3.2)
1.5
(1.0 - 2.0)
2.7
(2.1 - 3.2)
3.7
(3.1 - 4.3)
6.4
(4.6 - 8.1)
 
Table 13.3.3: Perfluorooctanoic acid (PFOA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c7 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c7 footnotes

Table c7 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c7 footnote a referrer

Table c7 footnote 2

Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c7 footnote b referrer

Males, Total 12-79 years
1Table c7 footnote b . . . . . . .
2 765 0 2.6
(2.4 - 2.8)
1.3
(1.0 - 1.6)
2.7
(2.5 - 2.9)
3.4
(3.1 - 3.7)
5.9
(4.3 - 7.6)
Males, 12-19 years
1Table c7 footnote b . . . . . . .
2 254 0 2.2
(2.1 - 2.3)
1.5
(1.3 - 1.6)
2.2
(2.0 - 2.3)
2.7
(2.5 - 2.9)
4.3
(3.6 - 4.9)
Males, 20-39 years
1 435 0 3.1
(2.8 - 3.4)
1.7
(1.5 - 1.9)
3.2
(3.0 - 3.5)
4.1
(3.7 - 4.4)
5.8
(5.1 - 6.5)
2 170 0 2.9
(2.6 - 3.3)
1.7
(1.1 - 2.3)
2.8
(2.3 - 3.3)
3.9
(3.0 - 4.9)
X
Males, 40-59 years
1 480 0.42 2.9
(2.6 - 3.1)
1.5
(1.3 - 1.7)
2.9
(2.6 - 3.3)
3.9
(3.5 - 4.3)
5.7
(4.9 - 6.5)
2 176 0 2.3
(2.0 - 2.5)
1.0
(0.79 - 1.3)
2.4
(2.0 - 2.8)
3.3
(2.9 - 3.7)
X
Males, 60-79 years
1 461 1.08 2.8
(2.5 - 3.2)
1.5
(1.2 - 1.8)
2.9
(2.6 - 3.2)
4.1
(3.5 - 4.7)
6.4
(5.3 - 7.6)
2 165 0 2.8
(2.5 - 3.1)
1.7
(1.2 - 2.2)
2.9
(2.5 - 3.3)
3.5
(3.1 - 3.9)
X
Females, Total 12-79 years
1Table c7 footnote b . . . . . . .
2 759 0 2.0
(1.8 - 2.2)
0.99
(0.81 - 1.2)
2.0
(1.8 - 2.2)
2.8
(2.3 - 3.4)
4.4
(3.9 - 4.9)
Females, 12-19 years
1Table c7 footnote b . . . . . . .
2 253 0 2.0
(1.7 - 2.3)
1.1
(0.91 - 1.2)
2.0
(1.6 - 2.4)
2.5
(2.2 - 2.8)
3.9
(3.5 - 4.4)
Females, 20-39 years
1 544 2.02 1.9
(1.7 - 2.1)
0.95
(0.75 - 1.1)
2.1
(1.8 - 2.3)
2.8
(2.5 - 3.1)
4.3
(3.7 - 5.0)
2 192 0 1.5
(1.3 - 1.8)
0.70
(0.59 - 0.81)
1.5
(1.2 - 1.9)
2.3
(1.9 - 2.6)
X
Females, 40-59 years
1 503 1.59 2.2
(2.0 - 2.4)
1.1
(0.90 - 1.3)
2.2
(2.0 - 2.4)
3.0
(2.8 - 3.2)
4.9
(4.1 - 5.8)
2 158 0 2.1
(1.8 - 2.4)
1.1
(0.86 - 1.3)
2.0
(1.5 - 2.5)
3.0
(2.1 - 3.8)
X
Females, 60-79 years
1 457 1.31 2.7
(2.4 - 3.0)
1.4
(1.2 - 1.7)
2.7
(2.5 - 2.9)
3.7
(3.3 - 4.1)
5.9
(5.3 - 6.5)
2 156 0 2.7
(2.2 - 3.5)
1.4E
(0.85 - 2.0)
2.5
(1.7 - 3.3)
3.9
(3.1 - 4.8)
X
 
Table 13.4.1: Perfluorononanoic acid (PFNA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c8 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c8 footnotes

Table c8 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c8 footnote a referrer

Total, 12-79 years
2 1524 1.05 0.82
(0.75 - 0.91)
0.39
(0.33 - 0.44)
0.80
(0.70 - 0.90)
1.1
(0.96 - 1.2)
1.9E
(1.1 - 2.7)
12-19 years
2 507 1.18 0.71
(0.62 - 0.81)
0.33
(0.27 - 0.38)
0.69
(0.63 - 0.75)
0.94
(0.83 - 1.0)
1.7E
(0.47 - 2.9)
20-39 years
2 362 2.21 0.79
(0.72 - 0.87)
0.38
(0.30 - 0.46)
0.77
(0.62 - 0.92)
1.1
(0.93 - 1.2)
F
40-59 years
2 334 0.60 0.79
(0.69 - 0.91)
0.41
(0.32 - 0.50)
0.78
(0.65 - 0.91)
1.0
(0.86 - 1.1)
1.7
(1.1 - 2.2)
60-79 years
2 321 0 1.1
(0.87 - 1.3)
0.45E
(0.25 - 0.65)
1.0
(0.86 - 1.1)
1.5
(1.1 - 1.8)
2.7E
(1.5 - 3.8)
 
Table 13.4.2: Perfluorononanoic acid (PFNA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c9 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c9 footnotes

Table c9 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c9 footnote a referrer

Males, Total 12-79 years
2 765 0.78 0.84
(0.75 - 0.94)
0.43
(0.37 - 0.48)
0.80
(0.69 - 0.91)
1.1
(0.94 - 1.3)
1.9
(1.5 - 2.2)
Males, 12-19 years
2 254 0.79 0.74
(0.63 - 0.86)
0.37
(0.29 - 0.44)
0.70
(0.65 - 0.75)
0.93
(0.80 - 1.1)
F
Males, 20-39 years
2 170 1.76 0.84
(0.71 - 1.0)
0.44E
(0.27 - 0.61)
0.84
(0.64 - 1.0)
1.1
(0.93 - 1.3)
X
Males, 40-59 years
2 176 0.57 0.77
(0.65 - 0.90)
0.40E
(0.20 - 0.61)
0.77
(0.65 - 0.89)
0.98
(0.81 - 1.1)
X
Males, 60-79 years
2 165 0 1.1
(0.90 - 1.2)
0.49E
(0.32 - 0.67)
0.99
(0.80 - 1.2)
1.5
(1.1 - 1.9)
X
Females, Total 12-79 years
2 759 1.32 0.81
(0.73 - 0.90)
0.35
(0.30 - 0.40)
0.79
(0.69 - 0.90)
1.1
(0.94 - 1.2)
2.3E
(1.2 - 3.4)
Females, 12-19 years
2 253 1.58 0.68
(0.57 - 0.80)
0.29
(0.22 - 0.37)
0.65
(0.52 - 0.78)
0.96
(0.76 - 1.2)
1.6
(1.2 - 2.0)
Females, 20-39 years
2 192 2.60 0.73
(0.64 - 0.83)
0.32
(0.24 - 0.39)
0.67
(0.53 - 0.81)
1.0
(0.88 - 1.2)
X
Females, 40-59 years
2 158 0.63 0.81
(0.69 - 0.96)
0.41
(0.32 - 0.50)
0.81
(0.62 - 1.0)
1.0
(0.81 - 1.2)
X
Females, 60-79 years
2 156 0 1.1
(0.81 - 1.4)
0.38E
(<LOD - 0.64)
1.0
(0.82 - 1.2)
1.5
(0.98 - 1.9)
X
 
Table 13.5.1: Perfluorodecanoic acid (PFDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c10 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c10 footnotes

Table c10 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c10 footnote a referrer

Total, 12-79 years
2 1524 21.59 0.20
(0.17 - 0.22)
<LOD 0.17
(0.15 - 0.19)
0.27
(0.23 - 0.30)
0.66
(0.45 - 0.87)
12-19 years
2 507 26.43 0.15
(0.13 - 0.18)
<LOD 0.14
(0.12 - 0.16)
0.20
(0.16 - 0.23)
0.39E
(0.22 - 0.55)
20-39 years
2 362 20.72 0.22
(0.20 - 0.23)
<LOD 0.17
(0.16 - 0.19)
0.27
(0.23 - 0.32)
F
40-59 years
2 334 21.56 0.17
(0.14 - 0.21)
<LOD 0.16
(0.13 - 0.19)
0.24
(0.20 - 0.28)
0.51
(0.35 - 0.66)
60-79 years
2 321 14.95 0.25
(0.17 - 0.36)
<LOD 0.23
(0.17 - 0.29)
0.37E
(0.15 - 0.59)
F
 
Table 13.5.2: Perfluorodecanoic acid (PFDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c11 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c11 footnotes

Table c11 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c11 footnote a referrer

Males, Total 12-79 years
2 765 20.39 0.20
(0.18 - 0.23)
<LOD 0.18
(0.15 - 0.20)
0.26
(0.23 - 0.30)
0.55
(0.41 - 0.70)
Males, 12-19 years
2 254 25.98 0.15
(0.13 - 0.18)
<LOD 0.14
(0.12 - 0.16)
0.20
(0.16 - 0.24)
0.38
(0.25 - 0.50)
Males, 20-39 years
2 170 19.41 0.21
(0.18 - 0.24)
<LOD 0.18
(0.15 - 0.21)
0.26
(0.21 - 0.31)
X
Males, 40-59 years
2 176 19.89 0.18
(0.15 - 0.23)
<LOD 0.17
(0.13 - 0.20)
0.25
(0.21 - 0.29)
X
Males, 60-79 years
2 165 13.33 0.26
(0.19 - 0.34)
<LOD 0.23
(0.18 - 0.29)
0.36E
(0.14 - 0.59)
X
Females, Total 12-79 years
2 759 22.79 0.19
(0.16 - 0.23)
<LOD 0.17
(0.14 - 0.19)
0.27
(0.22 - 0.33)
F
Females, 12-19 years
2 253 26.88 0.15
(0.12 - 0.20)
<LOD 0.14
(0.11 - 0.17)
0.20
(0.15 - 0.25)
0.40E
(0.20 - 0.60)
Females, 20-39 years
2 192 21.88 0.22
(0.18 - 0.27)
<LOD 0.17
(0.15 - 0.19)
0.30
(0.21 - 0.40)
X
Females, 40-59 years
2 158 23.42 0.16
(0.12 - 0.21)
<LOD 0.15
(<LOD - 0.21)
0.24
(0.18 - 0.29)
X
Females, 60-79 years
2 156 16.67 0.24E
(0.15 - 0.39)
<LOD 0.23E
(0.14 - 0.31)
0.37E
(0.13 - 0.61)
X
 
Table 13.6.1: Perfluoroundecanoic acid (PFUnDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c12 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c12 footnotes

Table c12 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c12 footnote a referrer

2 1522 39.29 0.12
(0.098 - 0.14)
<LOD 0.095
(<LOD - 0.10)
0.18
(0.14 - 0.22)
0.56E
(0.30 - 0.82)
12-19 years
2 506 58.30 -- <LOD <LOD 0.098
(<LOD - 0.12)
0.30
(0.21 - 0.38)
20-39 years
2 362 37.02 0.13
(0.10 - 0.16)
<LOD 0.098
(<LOD - 0.12)
0.20
(0.15 - 0.25)
0.64E
(0.22 - 1.1)
40-59 years
2 334 26.35 0.11
(0.094 - 0.14)
<LOD 0.095
(<LOD - 0.10)
0.16
(0.10 - 0.22)
0.43
(0.28 - 0.58)
60-79 years
2 320 25.31 0.14E
(<LOD - 0.23)
<LOD 0.11E
(<LOD - 0.17)
0.28E
(0.14 - 0.42)
0.84E
(0.42 - 1.3)
 
Table 13.6.2: Perfluoroundecanoic acid (PFUnDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c13 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c13 footnotes

Table c13 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c13 footnote a referrer

Males, Total 12-79 years
2 765 40.39 -- <LOD 0.094
(<LOD - 0.11)
0.19
(0.13 - 0.24)
0.47E
(0.27 - 0.67)
Males, 12-19 years
2 254 60.63 -- <LOD <LOD 0.098
(<LOD - 0.13)
0.32
(0.23 - 0.42)
Males, 20-39 years
2 170 38.24 0.11
(<LOD - 0.14)
<LOD 0.092E
(<LOD - 0.13)
0.18
(0.11 - 0.24)
X
Males, 40-59 years
2 176 28.98 0.12
(0.094 - 0.16)
<LOD 0.097E
(<LOD - 0.13)
0.19E
(0.091 - 0.29)
X
Males, 60-79 years
2 165 23.64 0.15E
(0.10 - 0.23)
<LOD 0.12E
(<LOD - 0.20)
0.32E
(0.16 - 0.48)
X
Females, Total 12-79 years
2 757 38.18 0.12
(0.10 - 0.15)
<LOD 0.096
(<LOD - 0.11)
0.18
(0.13 - 0.23)
0.63E
(0.24 - 1.0)
Females, 12-19 years
2 252 55.95 -- <LOD <LOD 0.098
(<LOD - 0.12)
0.24
(0.16 - 0.33)
Females, 20-39 years
2 192 35.94 0.15
(0.12 - 0.20)
<LOD 0.12
(<LOD - 0.16)
0.26E
(0.15 - 0.37)
X
Females, 40-59 years
2 158 23.42 0.11
(<LOD - 0.13)
<LOD 0.095
(<LOD - 0.11)
0.12E
(<LOD - 0.18)
X
Females, 60-79 years
2 155 27.10 0.14E
(<LOD - 0.24)
<LOD 0.10E
(<LOD - 0.17)
0.24E
(<LOD - 0.39)
X
 
Table 13.7.1: Perfluorobutane sulfonate (PFBS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c14 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c14 footnotes

Table c14 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c14 footnote a referrer

Total, 12-79 years
2 1524 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 507 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 362 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 334 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 321 100 -- <LOD <LOD <LOD <LOD
 
Table 13.7.2: Perfluorobutane sulfonate (PFBS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c15 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c15 footnotes

Table c15 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c15 footnote a referrer

Males, Total 12-79 years
2 765 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 254 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 170 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 176 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 165 100 -- <LOD <LOD <LOD X
Females, Total 12-79 years
2 759 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 253 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 192 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 158 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 156 100 -- <LOD <LOD <LOD X
 
Table 13.8.1: Perfluorohexane sulfonate (PFHxS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 20-79 years Table c16 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c16 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c16 footnotes

Table c16 footnote 1

For the purpose of total population comparisons, only values from participants aged 20-79 years were included as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c16 footnote a referrer

Table c16 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c16 footnote b referrer

Total, 20-79 years
1 2880 2.05 2.3
(2.0 - 2.6)
0.70
(0.50 - 0.89)
2.2
(1.8 - 2.5)
3.7
(3.2 - 4.1)
12
(9.2 - 15)
2 1015 1.38 1.7
(1.6 - 2.0)
0.55
(0.44 - 0.65)
1.7
(1.5 - 1.9)
2.7
(2.0 - 3.4)
8.9E
(4.6 - 13)
Males, 20-79 years
1 1376 0.58 3.2
(2.8 - 3.7)
1.3
(1.1 - 1.6)
2.8
(2.4 - 3.2)
4.6
(4.0 - 5.2)
16
(11 - 20)
2 510 0.59 2.4
(2.0 - 2.8)
0.94
(0.76 - 1.1)
2.1
(1.9 - 2.4)
3.6
(2.7 - 4.5)
9.4E
(4.9 - 14)
Females, 20-79 years
1 1504 3.39 1.6
(1.4 - 1.9)
0.50
(0.38 - 0.62)
1.5
(1.2 - 1.7)
2.7
(2.3 - 3.1)
8.5
(6.6 - 10)
2 505 2.18 1.3
(1.1 - 1.5)
0.40
(0.34 - 0.45)
1.2
(1.0 - 1.3)
2.0
(1.6 - 2.4)
8.2E
(3.4 - 13)
 
Table 13.8.2: Perfluorohexane sulfonate (PFHxS) - Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and Cycle 2 (2009-2011).
Cycle N %<LODTable c17 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c17 footnotes

Table c17 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c17 footnote a referrer

Table c17 footnote 2

Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c17 footnote b referrer

Total, 12-79 years
1Table c17 footnote b . . . . . . .
2 1521 1.25 1.8
(1.6 - 2.0)
0.55
(0.46 - 0.64)
1.7
(1.5 - 1.9)
2.8
(2.2 - 3.5)
9.0E
(4.9 - 13)
12-19 years
1Table c17 footnote b . . . . . . .
2 506 0.99 1.9
(1.6 - 2.3)
0.60
(0.50 - 0.70)
1.6
(1.3 - 1.9)
3.4
(2.3 - 4.5)
11E
(5.7 - 16)
20-39 years
1 979 3.06 2.1
(1.8 - 2.4)
0.61
(0.49 - 0.73)
1.9
(1.5 - 2.2)
3.6
(3.2 - 3.9)
16E
(10 - 23)
2 361 1.94 1.5
(1.3 - 1.9)
0.41
(0.28 - 0.54)
1.6
(1.1 - 2.1)
2.5E
(1.5 - 3.5)
6.0E
(2.1 - 9.9)
40-59 years
1 983 2.03 2.2
(1.9 - 2.5)
0.79
(0.54 - 1.0)
2.2
(1.8 - 2.5)
3.6
(3.0 - 4.2)
9.2
(7.4 - 11)
2 333 1.80 1.8
(1.4 - 2.3)
0.58E
(0.33 - 0.83)
1.7
(1.3 - 2.0)
2.6E
(1.5 - 3.6)
12E
(3.5 - 21)
60-79 years
1 918 0.98 2.8
(2.4 - 3.3)
1.1
(0.90 - 1.3)
2.6
(2.1 - 3.0)
4.3
(3.5 - 5.1)
13
(9.0 - 16)
2 321 0.31 2.2
(1.8 - 2.7)
0.86
(0.64 - 1.1)
2.0
(1.6 - 2.4)
3.4
(2.4 - 4.4)
9.8
(6.7 - 13)
 
Table 13.8.3: Perfluorohexane sulfonate (PFHxS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c18 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c18 footnotes

Table c18 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c18 footnote a referrer

Table c18 footnote 2

Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c18 footnote b referrer

Males, Total 12-79 years
1Table c18 footnote b . . . . . . .
2 763 0.66 2.4
(2.0 - 2.7)
0.92
(0.82 - 1.0)
2.1
(1.9 - 2.4)
3.6
(2.8 - 4.5)
9.9E
(5.5 - 14)
Males, 12-19 years
1Table c18 footnote b . . . . . . .
2 253 0.79 2.2
(1.8 - 2.8)
0.69
(0.49 - 0.90)
1.9
(1.3 - 2.4)
4.1E
(2.3 - 5.9)
F
Males, 20-39 years
1 435 0.23 3.3
(2.7 - 4.1)
1.2
(0.89 - 1.6)
2.8
(2.3 - 3.2)
4.7
(3.3 - 6.1)
F
2 169 0.59 2.4
(1.9 - 3.1)
0.91
(0.72 - 1.1)
2.1
(1.6 - 2.7)
3.7E
(2.2 - 5.3)
X
Males, 40-59 years
1 480 0.42 3.3
(2.8 - 3.8)
1.4
(1.1 - 1.7)
2.9
(2.4 - 3.4)
4.7
(3.4 - 6.0)
11E
(5.3 - 16)
2 176 1.14 2.2
(1.9 - 2.6)
1.2
(0.85 - 1.5)
2.2
(1.9 - 2.4)
3.0
(2.1 - 3.9)
X
Males, 60-79 years
1 461 1.08 3.0
(2.5 - 3.5)
1.2
(0.94 - 1.4)
2.8
(2.2 - 3.3)
4.3
(3.6 - 5.0)
12
(8.7 - 16)
2 165 0 2.4
(2.0 - 3.0)
0.92
(0.69 - 1.2)
2.2
(1.7 - 2.6)
3.8
(2.5 - 5.0)
X
Females, Total 12-79 years
1Table c18 footnote b . . . . . . .
2 758 1.85 1.3
(1.1 - 1.5)
0.41
(0.36 - 0.46)
1.2
(1.0 - 1.3)
2.1
(1.7 - 2.4)
8.5E
(3.7 - 13)
Females, 12-19 years
1Table c18 footnote b . . . . . . .
2 253 1.19 1.6
(1.2 - 2.0)
0.54
(0.41 - 0.68)
1.2
(0.89 - 1.6)
2.4E
(1.4 - 3.4)
9.0E
(3.5 - 14)
Females, 20-39 years
1 544 5.33 1.3
(1.1 - 1.6)
0.37E
(<LOD - 0.56)
1.2
(1.0 - 1.3)
2.1
(1.5 - 2.8)
8.0E
(4.2 - 12)
2 192 3.13 0.86
(0.68 - 1.1)
0.25E
(<LOD - 0.42)
0.99
(0.86 - 1.1)
1.3
(0.97 - 1.7)
X
Females, 40-59 years
1 503 3.58 1.5
(1.3 - 1.8)
0.47
(0.32 - 0.62)
1.4
(1.1 - 1.7)
2.5
(2.1 - 2.9)
6.6
(4.9 - 8.4)
2 157 2.55 1.5E
(0.95 - 2.3)
0.51
(0.34 - 0.69)
1.1
(0.78 - 1.5)
F X
Females, 60-79 years
1 457 0.88 2.7
(2.2 - 3.3)
1.0
(0.78 - 1.3)
2.3
(1.9 - 2.8)
4.0
(2.7 - 5.2)
13E
(6.9 - 19)
2 156 0.64 2.0
(1.5 - 2.6)
0.68E
(0.27 - 1.1)
1.9
(1.3 - 2.4)
3.2
(2.2 - 4.3)
X
 
Table 13.9.1: Perfluorooctane sulfonate (PFOS) -- Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 20-79 years Table c19 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c19 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c19 footnotes

Table c19 footnote 1

For the purpose of total population comparisons, only values from participants aged 20-79 years were included as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c19 footnote a referrer

Table c19 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c19 footnote b referrer

Total, 20-79 years
1 2880 0.14 8.9
(8.0 - 9.8)
3.6
(3.1 - 4.1)
9.1
(8.1 - 10)
13
(12 - 15)
27
(22 - 32)
2 1017 0.39 6.9
(6.2 - 7.6)
2.6
(1.9 - 3.2)
6.8
(6.0 - 7.6)
11
(9.5 - 12)
19
(13 - 25)
Males, 20-79 years
1 1376 0.07 11
(10 - 12)
5.1
(4.3 - 6.0)
11
(9.5 - 12)
16
(14 - 18)
31
(23 - 39)
2 511 0.39 8.3
(7.4 - 9.3)
4.7
(3.6 - 5.8)
8.2
(6.6 - 9.8)
12
(9.9 - 14)
19
(14 - 25)
Females, 20-79 years
1 1504 0.20 7.1
(6.3 - 7.9)
3.0
(2.6 - 3.4)
7.4
(6.4 - 8.4)
11
(9.6 - 12)
20
(15 - 24)
2 506 0.40 5.7
(4.9 - 6.6)
2.0
(1.5 - 2.4)
6.0
(5.1 - 6.9)
9.0
(7.1 - 11)
19E
(7.8 - 30)
 
Table 13.9.2: Perfluorooctane sulfonate (PFOS) - Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and Cycle 2 (2009-2011).
Cycle N %<LODTable c20 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c20 footnotes

Table c20 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c20 footnote a referrer

Table c20 footnote 2

Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c20 footnote b referrer

Total, 12-79 years
1Table c20 footnote b . . . . . . .
2 1524 0.33 6.5
(5.9 - 7.2)
2.4
(2.0 - 2.8)
6.7
(6.1 - 7.3)
10
(9.3 - 11)
18
(13 - 23)
12-19 years
1Table c20 footnote b . . . . . . .
2 507 0.20 4.6
(4.0 - 5.2)
2.1
(1.9 - 2.4)
4.6
(3.9 - 5.3)
6.6
(5.7 - 7.5)
11
(9.2 - 13)
20-39 years
1 979 0.10 8.2
(7.2 - 9.3)
3.5
(2.8 - 4.1)
8.6
(7.3 - 9.9)
12
(11 - 14)
21
(19 - 24)
2 362 0.55 6.2
(5.4 - 7.1)
2.1E
(0.99 - 3.2)
6.7
(5.8 - 7.6)
10
(7.4 - 13)
19E
(9.6 - 29)
40-59 years
1 983 0.31 8.6
(7.7 - 9.5)
3.4
(2.8 - 4.0)
8.8
(7.9 - 9.7)
13
(11 - 15)
28
(19 - 37)
2 334 0.60 6.4
(5.7 - 7.2)
2.3
(1.6 - 3.0)
6.7
(5.7 - 7.7)
10
(8.7 - 11)
16
(13 - 19)
60-79 years
1 918 0 11
(9.6 - 13)
4.4
(3.3 - 5.5)
11
(9.6 - 13)
17
(14 - 19)
30
(24 - 35)
2 321 0 9.4
(8.3 - 11)
4.6
(3.9 - 5.3)
9.8
(8.1 - 11)
15
(13 - 16)
21E
(7.5 - 35)
 
Table 13.9.3: Perfluorooctane sulfonate (PFOS) -- Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c21 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c21 footnotes

Table c21 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c21 footnote a referrer

Table c21 footnote 2

Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009).

Return to table c21 footnote b referrer

Males, Total 12-79 years
1Table c21 footnote b . . . . . . .
2 765 0.26 7.8
(7.1 - 8.7)
3.8
(2.8 - 4.8)
7.6
(6.3 - 9.0)
11
(9.8 - 13)
19
(14 - 24)
Males, 12-19 years
1Table c21 footnote b . . . . . . .
2 254 0 5.1
(4.6 - 5.7)
2.4
(2.1 - 2.6)
5.2
(4.6 - 5.7)
7.1
(6.0 - 8.3)
13E
(7.5 - 18)
Males, 20-39 years
1 435 0 10
(9.2 - 12)
5.3
(4.3 - 6.2)
10
(9.2 - 11)
14
(13 - 16)
27
(20 - 35)
2 170 0.59 8.2
(6.8 - 10)
4.8
(4.1 - 5.4)
7.6E
(4.7 - 11)
12
(8.9 - 14)
X
Males, 40-59 years
1 480 0.21 11
(10 - 13)
5.0
(4.0 - 6.0)
11
(9.1 - 12)
16
(14 - 18)
34
(22 - 46)
2 176 0.57 7.5
(6.7 - 8.4)
3.2E
(1.8 - 4.7)
7.6
(6.7 - 8.5)
10
(9.2 - 12)
X
Males, 60-79 years
1 461 0 12
(10 - 14)
5.0E
(3.0 - 6.9)
12
(9.5 - 14)
18
(14 - 22)
35
(23 - 46)
2 165 0 10
(8.9 - 12)
4.7
(3.4 - 6.0)
11
(7.9 - 14)
15
(13 - 17)
X
Females, Total 12-79 years
1Table c21 footnote b . . . . . . .
2 759 0.40 5.5
(4.8 - 6.2)
2.0
(1.6 - 2.3)
5.7
(4.8 - 6.5)
8.4
(6.8 - 10)
18E
(9.7 - 27)
Females, 12-19 years
1Table c21 footnote b . . . . . . .
2 253 0.40 4.1
(3.4 - 4.8)
2.0
(1.7 - 2.3)
4.0
(3.2 - 4.8)
6.1
(5.0 - 7.3)
9.0
(7.3 - 11)
Females, 20-39 years
1 544 0.18 6.4
(5.4 - 7.5)
3.0
(2.6 - 3.4)
6.4
(5.1 - 7.7)
9.8
(7.7 - 12)
16
(14 - 19)
2 192 0.52 4.4
(3.5 - 5.6)
1.6E
(0.97 - 2.3)
4.3
(2.9 - 5.8)
6.7
(5.8 - 7.7)
X
Females, 40-59 years
1 503 0.40 6.5
(5.8 - 7.3)
2.8
(2.2 - 3.3)
6.9
(6.0 - 7.9)
9.9
(9.3 - 11)
17
(12 - 22)
2 158 0.63 5.6
(4.6 - 6.8)
2.2E
(1.4 - 3.0)
6.2
(4.5 - 7.9)
9.3
(6.6 - 12)
X
Females, 60-79 years
1 457 0 10
(8.6 - 12)
4.1
(3.0 - 5.1)
10
(8.8 - 12)
15
(12 - 17)
27
(22 - 31)
2 156 0 8.8
(7.2 - 11)
4.3
(2.9 - 5.6)
8.4
(5.5 - 11)
14
(9.9 - 18)
X
 
Table 14.1.1.1: Atrazine mercapturate (AM) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c22 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c22 footnotes

Table c22 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c22 footnote a referrer

Total, 3-79 years
2 2526 99.88 -- <LOD <LOD <LOD <LOD
3-5 years
2 508 99.80 -- <LOD <LOD <LOD <LOD
6-11 years
2 511 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 506 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 355 99.72 -- <LOD <LOD <LOD <LOD
40-59 years
2 359 99.72 -- <LOD <LOD <LOD <LOD
60-79 years
2 287 100 -- <LOD <LOD <LOD <LOD
 
Table 14.1.1.2: Atrazine mercapturate (AM) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c23 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c23 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c23 footnotes

Table c23 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c23 footnote a referrer

Table c23 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c23 footnote b referrer

Males, Total 3-79 years
2 1268 99.92 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 261 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 255 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 166 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 99.48 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1258 99.84 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 250 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 251 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 189 99.47 -- <LOD <LOD <LOD X
Females, 40-59 years
2 166 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 145 100 -- <LOD <LOD <LOD X
 
Table 14.1.1.3: Atrazine mercapturate (AM) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c24 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c24 footnotes

Table c24 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c24 footnote a referrer

Total, 3-79 years
2 2516 100 -- <LOD <LOD <LOD <LOD
3-5 years
2 507 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 509 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 504 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 353 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 357 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 286 100 -- <LOD <LOD <LOD <LOD
 
Table 14.1.1.4: Atrazine mercapturate (AM) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c25 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c25 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c25 footnotes

Table c25 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c25 footnote a referrer

Table c25 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c25 footnote b referrer

Males, Total 3-79 years
2 1264 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 260 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 254 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 165 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 99.48 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1252 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 249 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 250 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 188 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 164 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 144 100 -- <LOD <LOD <LOD X
 
Table 14.1.2.1: Diaminochlorotriazine (DACT) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c26 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c26 footnotes

Table c26 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c26 footnote a referrer

Total, 3-79 years
2 2526 100 -- <LOD <LOD <LOD <LOD
3-5 years
2 508 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 511 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 506 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 355 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 359 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 287 100 -- <LOD <LOD <LOD <LOD
 
Table 14.1.2.2: Diaminochlorotriazine (DACT) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c27 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c27 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c27 footnotes

Table c27 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c27 footnote a referrer

Table c27 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c27 footnote b referrer

Males, Total 3-79 years
2 1268 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 261 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 255 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 166 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1258 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 250 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 251 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 189 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 166 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 145 100 -- <LOD <LOD <LOD X
 
Table 14.1.2.3: Diaminochlorotriazine (DACT) (creatinine adjusted) - Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c28 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c28 footnotes

Table c28 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c28 footnote a referrer

Total, 3-79 years
2 2516 100 -- <LOD <LOD <LOD <LOD
3-5 years
2 507 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 509 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 504 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 353 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 357 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 286 100 -- <LOD <LOD <LOD <LOD
 
Table 14.1.2.4: Diaminochlorotriazine (DACT) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c29 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c29 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c29 footnotes

Table c29 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c29 footnote a referrer

Table c29 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c29 footnote b referrer

Males, Total 3-79 years
2 1264 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 260 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 254 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 165 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1252 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 249 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 250 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 188 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 164 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 144 100 -- <LOD <LOD <LOD X
 
Table 14.1.3.1: Desethylatrazine (DEA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c30 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c30 footnotes

Table c30 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c30 footnote a referrer

Total, 3-79 years
2 2526 100 -- <LOD <LOD <LOD <LOD
3-5 years
2 508 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 511 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 506 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 355 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 359 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 287 100 -- <LOD <LOD <LOD <LOD
 
Table 14.1.3.2: Desethylatrazine (DEA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c31 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c31 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c31 footnotes

Table c31 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c31 footnote a referrer

Table c31 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c31 footnote b referrer

Males, Total 3-79 years
2 1268 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 261 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 255 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 166 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1258 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 250 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 251 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 189 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 166 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 145 100 -- <LOD <LOD <LOD X
 
Table 14.1.3.3: Desethylatrazine (DEA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c32 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c32 footnotes

Table c32 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c32 footnote a referrer

2 2516 100 -- <LOD <LOD <LOD <LOD
3-5 years
2 507 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 509 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 504 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 353 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 357 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 286 100 -- <LOD <LOD <LOD <LOD
 
Table 14.1.3.4: Desethylatrazine (DEA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c33 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c33 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c33 footnotes

Table c33 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c33 footnote a referrer

Table c33 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c33 footnote b referrer

Males, Total 3-79 years
2 1264 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 260 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 254 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 165 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 193 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1252 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 249 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 250 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 188 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 164 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 144 100 -- <LOD <LOD <LOD X
 
Table 14.2.1.1: Carbofuranphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c34 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c34 footnotes

Table c34 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c34 footnote a referrer

Total, 3-79 years
2 2557 99.96 -- <LOD <LOD <LOD <LOD
3-5 years
2 522 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 516 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 511 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 357 99.72 -- <LOD <LOD <LOD <LOD
40-59 years
2 360 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 291 100 -- <LOD <LOD <LOD <LOD
 
Table 14.2.1.2: Carbofuranphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c35 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c35 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c35 footnotes

Table c35 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c35 footnote a referrer

Table c35 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c35 footnote b referrer

Males, Total 3-79 years
2 1279 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 262 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 256 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 167 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 194 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1278 99.92 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 254 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 255 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 190 99.47 -- <LOD <LOD <LOD X
Females, 40-59 years
2 166 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 149 100 -- <LOD <LOD <LOD X
 
Table 14.2.1.3: Carbofuranphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c36 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c36 footnotes

Table c36 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c36 footnote a referrer

Total, 3-79 years
2 2547 100 -- <LOD <LOD <LOD <LOD
3-5 years
2 521 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 514 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 509 100 -- <LOD <LOD <LOD <LOD
20-39 years
2 355 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 358 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 290 100 -- <LOD <LOD <LOD <LOD
 
Table 14.2.1.4: Carbofuranphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c37 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c37 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c37 footnotes

Table c37 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c37 footnote a referrer

Table c37 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c37 footnote b referrer

Males, Total 3-79 years
2 1275 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 261 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 255 100 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 166 100 -- <LOD <LOD <LOD X
Males, 40-59 years
2 194 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1272 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 253 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 254 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 189 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 164 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 148 100 -- <LOD <LOD <LOD X
 
Table 14.2.2.1: 2-Isopropoxyphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c38 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c38 footnotes

Table c38 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c38 footnote a referrer

Total, 3-79 years
2 2560 99.8 -- <LOD <LOD <LOD <LOD
3-5 years
2 524 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 516 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 512 99.41 -- <LOD <LOD <LOD <LOD
20-39 years
2 357 99.44 -- <LOD <LOD <LOD <LOD
40-59 years
2 360 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 291 100 -- <LOD <LOD <LOD <LOD
 
Table 14.2.2.2: 2-Isopropoxyphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c39 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c39 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c39 footnotes

Table c39 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c39 footnote a referrer

Table c39 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c39 footnote b referrer

Males, Total 3-79 years
2 1281 99.69 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 262 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 256 99.22 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 167 98.80 -- <LOD <LOD <LOD X
Males, 40-59 years
2 194 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1279 99.92 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 254 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 256 99.61 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 190 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 166 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 149 100 -- <LOD <LOD <LOD X
 
Table 14.2.2.3: 2-Isopropoxyphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c40 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c40 footnotes

Table c40 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c40 footnote a referrer

Total, 3-79 years
2 2550 100 -- <LOD <LOD <LOD <LOD
3-5 years
2 523 100 -- <LOD <LOD <LOD <LOD
6-11 years
2 514 100 -- <LOD <LOD <LOD <LOD
12-19 years
2 510 99.80 -- <LOD <LOD <LOD <LOD
20-39 years
2 355 100 -- <LOD <LOD <LOD <LOD
40-59 years
2 358 100 -- <LOD <LOD <LOD <LOD
60-79 years
2 290 100 -- <LOD <LOD <LOD <LOD
 
Table 14.2.2.4: 2-Isopropoxyphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c41 footnote a, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle N %<LODTable c41 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c41 footnotes

Table c41 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c41 footnote a referrer

Table c41 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c41 footnote b referrer

Males, Total 3-79 years
2 1277 100 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
2 261 100 -- <LOD <LOD <LOD <LOD
Males, 12-19 years
2 255 99.61 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
2 166 99.40 -- <LOD <LOD <LOD X
Males, 40-59 years
2 194 100 -- <LOD <LOD <LOD X
Males, 60-79 years
2 142 100 -- <LOD <LOD <LOD X
Females, Total 3-79 years
2 1273 100 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
2 253 100 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
2 255 100 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
2 189 100 -- <LOD <LOD <LOD X
Females, 40-59 years
2 164 100 -- <LOD <LOD <LOD X
Females, 60-79 years
2 148 100 -- <LOD <LOD <LOD X
 
Table 14.3.1: 2,4-Dichlorophenoxyacetic acid (2,4-D) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c42 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c42 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c42 footnotes

Table c42 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c42 footnote a referrer

Table c42 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c42 footnote b referrer

Total, 6-79 years
1 5480 58.10 -- <LOD <LOD 0.29
(0.21 - 0.36)
0.91
(0.73 - 1.1)
2 2028 43.44 -- <LOD 0.22
(<LOD - 0.26)
0.40
(0.34 - 0.45)
1.0
(0.86 - 1.2)
Males, 6-79 years
1 2661 55.20 -- <LOD <LOD 0.33
(0.25 - 0.40)
1.0
(0.71 - 1.3)
2 1016 37.20 0.26
(0.22 - 0.30)
<LOD 0.24
(0.21 - 0.28)
0.46
(0.37 - 0.55)
1.2
(0.96 - 1.5)
Females, 6-79 years
1 2819 60.84 -- <LOD <LOD 0.26
(<LOD - 0.34)
0.75
(0.63 - 0.87)
2 1012 49.70 -- <LOD <LOD 0.34
(0.28 - 0.40)
0.80
(0.56 - 1.0)
 
Table 14.3.2: 2,4-Dichlorophenoxyacetic acid (2,4-D) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c43 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c43 footnotes

Table c43 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c43 footnote a referrer

Table c43 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c43 footnote b referrer

Total, 3-79 years
1Table c43 footnote b . . . . . . .
2 2551 41.98 -- <LOD 0.22
(<LOD - 0.26)
0.40
(0.35 - 0.45)
1.0
(0.87 - 1.2)
3-5 years
1Table c43 footnote b . . . . . . .
2 523 36.33 0.26
(0.23 - 0.30)
<LOD 0.26
(0.20 - 0.31)
0.46
(0.37 - 0.55)
1.1
(0.81 - 1.4)
6-11 years
1 1030 57.48 -- <LOD <LOD 0.32
(0.22 - 0.42)
0.92
(0.66 - 1.2)
2 512 42.38 -- <LOD 0.26
(0.22 - 0.30)
0.45
(0.38 - 0.53)
1.2E
(0.78 - 1.7)
12-19 years
1 981 56.17 -- <LOD <LOD 0.30E
(<LOD - 0.41)
0.75
(0.66 - 0.84)
2 511 41.68 -- <LOD 0.23
(<LOD - 0.26)
0.40
(0.30 - 0.50)
0.98
(0.73 - 1.2)
20-39 years
1 1166 61.66 -- <LOD <LOD 0.26
(<LOD - 0.33)
0.73
(0.55 - 0.90)
2 357 46.22 -- <LOD 0.21
(<LOD - 0.25)
0.34
(0.26 - 0.41)
0.69E
(0.34 - 1.0)
40-59 years
1 1222 60.31 -- <LOD <LOD 0.28
(0.20 - 0.36)
0.99
(0.64 - 1.3)
2 357 43.70 -- <LOD 0.24
(<LOD - 0.32)
0.42
(0.32 - 0.51)
1.1
(0.77 - 1.4)
60-79 years
1 1081 54.12 -- <LOD <LOD 0.36
(0.30 - 0.43)
1.1E
(0.72 - 1.6)
2 291 44.67 -- <LOD <LOD 0.43
(0.29 - 0.56)
1.2E
(0.54 - 1.9)
 
Table 14.3.3: 2,4-Dichlorophenoxyacetic acid (2,4-D) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group3, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c44 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c44 footnotes

Table c44 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c44 footnote a referrer

Table c44 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c44 footnote b referrer

Table c44 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c44 footnote c referrer

Males, Total 3-79 years
1Table c44 footnote c . . . . . . .
2 1275 36.16 0.26
(0.22 - 0.30)
<LOD 0.24
(0.21 - 0.28)
0.46
(0.37 - 0.54)
1.2
(0.98 - 1.5)
Males, 6-11 years
1 525 56.57 -- <LOD <LOD 0.32
(0.22 - 0.43)
1.0
(0.73 - 1.3)
2 260 36.54 0.25
(0.21 - 0.29)
<LOD 0.26
(0.20 - 0.33)
0.44
(0.35 - 0.53)
1.2E
(0.74 - 1.7)
Males, 12-19 years
1 504 54.76 -- <LOD <LOD 0.27
(<LOD - 0.36)
0.70
(0.48 - 0.92)
2 255 40.39 -- <LOD 0.24
(<LOD - 0.29)
0.40
(0.27 - 0.53)
0.96
(0.71 - 1.2)
Males, 20-39 years
1 513 57.70 -- <LOD <LOD 0.28
(0.20 - 0.36)
0.90
(0.69 - 1.1)
2 167 33.53 0.24
(0.20 - 0.29)
<LOD 0.24
(0.21 - 0.28)
0.38
(0.27 - 0.50)
X
Males, 40-59 years
1 578 57.61 -- <LOD <LOD 0.33
(0.26 - 0.40)
1.2E
(0.70 - 1.6)
2 192 33.33 0.29
(0.21 - 0.39)
<LOD 0.26E
(<LOD - 0.36)
0.59E
(0.31 - 0.88)
X
Males, 60-79 years
1 541 49.35 -- <LOD F 0.41
(0.32 - 0.49)
1.3E
(0.70 - 2.0)
2 142 42.25 -- <LOD 0.21E
(<LOD - 0.30)
0.54E
(0.26 - 0.82)
X
Females, Total 3-79 years
1Table c44 footnote c . . . . . . .
2 1276 47.81 -- <LOD <LOD 0.35
(0.29 - 0.40)
0.80
(0.57 - 1.0)
Females, 6-11 years
1 505 58.42 -- <LOD <LOD 0.31E
(<LOD - 0.44)
0.89E
(0.52 - 1.3)
2 252 48.41 -- <LOD 0.26
(0.20 - 0.31)
0.48
(0.35 - 0.60)
1.2E
(0.75 - 1.7)
Females, 12-19 years
1 477 57.65 -- <LOD <LOD 0.37E
(0.20 - 0.54)
0.79
(0.70 - 0.87)
2 256 42.97 -- <LOD 0.21
(<LOD - 0.26)
0.39
(0.27 - 0.51)
1.2E
(0.63 - 1.8)
Females, 20-39 years
1 653 64.78 -- <LOD <LOD 0.24
(<LOD - 0.31)
0.57
(0.43 - 0.70)
2 190 57.37 -- <LOD <LOD 0.32
(0.23 - 0.41)
X
Females, 40-59 years
1 644 62.73 -- <LOD <LOD 0.22E
(<LOD - 0.32)
0.72E
(0.46 - 0.99)
2 165 55.76 -- <LOD <LOD 0.35
(0.25 - 0.46)
X
Females, 60-79 years
1 540 58.89 -- <LOD <LOD 0.31E
(<LOD - 0.43)
0.99
(0.82 - 1.2)
2 149 46.98 -- <LOD <LOD 0.35E
(0.20 - 0.50)
X
 
Table 14.3.4: 2,4-Dichlorophenoxyacetic acid (2,4-D) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c45 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c45 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c45 footnotes

Table c45 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c45 footnote a referrer

Table c45 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c45 footnote b referrer

Total, 6-79 years
1 5466 58.25 -- <LOD <LOD 0.39
(0.36 - 0.42)
1.0
(0.93 - 1.2)
2 2019 43.64 -- <LOD 0.21
(<LOD - 0.23)
0.38
(0.34 - 0.42)
1.0
(0.82 - 1.2)
Males, 6-79 years
1 2652 55.39 -- <LOD <LOD 0.34
(0.29 - 0.38)
0.95
(0.78 - 1.1)
2 1013 37.31 0.21
(0.19 - 0.24)
<LOD 0.20
(0.15 - 0.24)
0.38
(0.33 - 0.42)
1.2
(0.85 - 1.5)
Females, 6-79 years
1 2814 60.95 -- <LOD <LOD 0.45
(<LOD - 0.49)
1.1
(1.0 - 1.2)
2 1006 50.00 -- <LOD <LOD 0.40
(0.33 - 0.47)
0.88
(0.65 - 1.1)
 
Table 14.3.5: 2,4-Dichlorophenoxyacetic acid (2,4-D) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c46 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c46 footnotes

Table c46 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c46 footnote a referrer

Table c46 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c46 footnote b referrer

Total, 3-79 years
1Table c46 footnote b . . . . . . .
2 2541 42.15 -- <LOD 0.21
(<LOD - 0.24)
0.40
(0.36 - 0.44)
1.1
(0.87 - 1.2)
3-5 years
1Table c46 footnote b . . . . . . .
2 522 36.40 0.45
(0.39 - 0.52)
<LOD 0.40
(0.30 - 0.51)
0.82
(0.68 - 0.96)
2.2
(1.5 - 2.9)
6-11 years
1 1027 57.64 -- <LOD <LOD 0.51
(0.44 - 0.58)
1.5
(1.2 - 1.8)
2 510 42.55 -- <LOD 0.28
(0.24 - 0.31)
0.51
(0.42 - 0.60)
1.2
(0.79 - 1.6)
12-19 years
1 979 56.28 -- <LOD <LOD 0.29
(<LOD - 0.34)
0.67
(0.58 - 0.76)
2 509 41.85 -- <LOD 0.16
(<LOD - 0.20)
0.30
(0.21 - 0.40)
0.68E
(0.43 - 0.93)
20-39 years
1 1162 61.88 -- <LOD <LOD 0.33
(<LOD - 0.36)
0.91
(0.65 - 1.2)
2 355 46.48 -- <LOD 0.16
(<LOD - 0.19)
0.32
(0.24 - 0.40)
0.74
(0.51 - 0.96)
40-59 years
1 1217 60.56 -- <LOD <LOD 0.41
(0.35 - 0.47)
1.1
(0.87 - 1.3)
2 355 43.94 -- <LOD 0.25
(<LOD - 0.32)
0.40
(0.33 - 0.48)
0.88E
(0.54 - 1.2)
60-79 years
1 1081 54.12 -- <LOD <LOD 0.52
(0.45 - 0.59)
1.4
(1.1 - 1.7)
2 290 44.83 -- <LOD <LOD 0.49
(0.38 - 0.60)
1.7E
(1.1 - 2.3)
 
Table 14.3.6: 2,4-Dichlorophenoxyacetic acid (2,4-D) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group3, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c47 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c47 footnotes

Table c47 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c47 footnote a referrer

Table c47 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c47 footnote b referrer

Table c47 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c47 footnote c referrer

Males, Total 3-79 years
1Table c47 footnote c . . . . . . .
2 1271 36.27 0.22
(0.20 - 0.24)
<LOD 0.20
(0.16 - 0.24)
0.38
(0.35 - 0.42)
1.2
(0.94 - 1.4)
Males, 6-11 years
1 523 56.79 -- <LOD <LOD 0.51
(0.39 - 0.63)
1.5
(1.1 - 1.9)
2 259 36.68 0.28
(0.22 - 0.36)
<LOD 0.28
(0.23 - 0.33)
0.55
(0.42 - 0.68)
1.2
(0.82 - 1.5)
Males, 12-19 years
1 503 54.87 -- <LOD <LOD 0.27
(<LOD - 0.32)
0.57
(0.50 - 0.63)
2 254 40.55 -- <LOD 0.16
(<LOD - 0.20)
0.30
(0.20 - 0.41)
0.63
(0.43 - 0.82)
Males, 20-39 years
1 511 57.93 -- <LOD <LOD 0.30
(0.24 - 0.36)
0.78
(0.57 - 0.99)
2 166 33.73 0.18
(0.14 - 0.22)
<LOD 0.15
(0.12 - 0.19)
0.27E
(0.14 - 0.39)
X
Males, 40-59 years
1 574 58.01 -- <LOD <LOD 0.33
(0.28 - 0.38)
0.99E
(0.56 - 1.4)
2 192 33.33 0.24
(0.19 - 0.31)
<LOD 0.25
(<LOD - 0.34)
0.39
(0.30 - 0.49)
X
Males, 60-79 years
1 541 49.35 -- <LOD <LOD
(<LOD - 0.26)
0.40
(0.28 - 0.51)
1.2E
(0.71 - 1.7)
2 142 42.25 -- <LOD 0.20E
(<LOD - 0.31)
0.44
(0.31 - 0.58)
X
Females, Total 3-79 years
1Table c47 footnote c . . . . . . .
2 1270 48.03 -- <LOD <LOD 0.42
(0.35 - 0.49)
0.91
(0.67 - 1.2)
Females, 6-11 years
1 504 58.53 -- <LOD <LOD 0.51
(<LOD - 0.61)
1.5E
(0.88 - 2.1)
2 251 48.61 -- <LOD 0.28
(0.24 - 0.31)
0.48
(0.39 - 0.57)
1.5E
(0.80 - 2.2)
Females, 12-19 years
1 476 57.77 -- <LOD <LOD 0.31
(0.26 - 0.36)
0.71
(0.58 - 0.84)
2 255 43.14 -- <LOD 0.17
(<LOD - 0.20)
0.31E
(0.20 - 0.43)
0.88E
(0.46 - 1.3)
Females, 20-39 years
1 651 64.98 -- <LOD <LOD 0.38
(<LOD - 0.43)
0.98
(0.71 - 1.3)
2 189 57.67 -- <LOD <LOD 0.36E
(0.23 - 0.49)
X
Females, 40-59 years
1 643 62.83 -- <LOD <LOD 0.47
(<LOD - 0.52)
1.2
(0.98 - 1.3)
2 163 56.44 -- <LOD <LOD 0.42
(0.31 - 0.53)
X
Females, 60-79 years
1 540 58.89 -- <LOD <LOD 0.61
(<LOD - 0.72)
1.6
(1.3 - 1.9)
2 148 47.30 -- <LOD <LOD 0.51
(0.38 - 0.64)
X
 
Table 14.4.1.1: Dimethylphosphate (DMP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c48 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c48 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c48 footnotes

Table c48 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c48 footnote a referrer

Table c48 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c48 footnote b referrer

Total, 6-79 years
1 5467 20.27 2.8
(2.4 - 3.3)
<LOD 3.0
(2.5 - 3.6)
7.3
(6.6 - 7.9)
25
(21 - 28)
2 2034 15.19 3.2
(2.8 - 3.7)
<LOD 3.4
(2.9 - 4.0)
7.3
(6.4 - 8.2)
25
(21 - 29)
Males, 6-79 years
1 2653 19.68 2.8
(2.4 - 3.4)
<LOD 3.1
(2.4 - 3.8)
7.3
(6.6 - 8.1)
25
(20 - 30)
2 1020 15.39 3.2
(2.7 - 3.7)
<LOD 3.3
(2.7 - 4.0)
6.9
(5.5 - 8.4)
26
(21 - 30)
Females, 6-79 years
1 2814 20.82 2.7
(2.2 - 3.3)
<LOD 3.0
(2.4 - 3.6)
7.2
(6.1 - 8.2)
24
(20 - 29)
2 1014 14.99 3.3
(2.8 - 3.9)
<LOD 3.6
(2.7 - 4.4)
7.4
(6.2 - 8.7)
24
(17 - 31)
 
Table 14.4.1.2: Dimethylphosphate (DMP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c49 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c49 footnotes

Table c49 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c49 footnote a referrer

Table c49 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c49 footnote b referrer

Total, 3-79 years
1Table c49 footnote b . . . . . . .
2 2556 13.58 3.3
(2.9 - 3.8)
<LOD 3.5
(3.0 - 4.0)
7.4
(6.6 - 8.2)
26
(22 - 29)
3-5 years
1Table c49 footnote b . . . . . . .
2 522 7.28 6.7
(5.6 - 8.1)
1.4
(1.0 - 1.8)
6.8
(4.9 - 8.6)
15
(12 - 17)
F
6-11 years
1 1028 17.51 3.7
(3.1 - 4.4)
<LOD 4.3
(3.9 - 4.8)
11
(9.3 - 13)
29
(23 - 36)
2 516 10.27 6.1
(5.1 - 7.2)
1.3E
(<LOD - 2.0)
5.9
(4.6 - 7.3)
13
(9.5 - 17)
F
12-19 years
1 980 15.71 3.8
(3.1 - 4.6)
<LOD 4.1
(3.3 - 4.9)
10
(8.7 - 11)
28
(23 - 32)
2 512 10.74 3.8
(3.2 - 4.5)
<LOD 4.0
(3.2 - 4.8)
8.2
(6.6 - 9.7)
30
(19 - 41)
20-39 years
1 1162 23.06 2.6
(2.1 - 3.1)
<LOD 2.9
(2.2 - 3.7)
6.2
(5.3 - 7.0)
23E
(10 - 36)
2 356 22.19 3.1
(2.4 - 4.0)
<LOD 3.5
(2.6 - 4.5)
6.5
(4.4 - 8.5)
29
(20 - 39)
40-59 years
1 1221 26.29 2.5
(2.0 - 3.2)
<LOD 2.9E
(1.4 - 4.4)
6.7
(5.3 - 8.2)
24
(18 - 31)
2 360 19.44 2.8
(2.2 - 3.7)
<LOD 2.8
(2.1 - 3.5)
6.3
(4.9 - 7.6)
20E
(12 - 27)
60-79 years
1 1076 17.19 2.9
(2.5 - 3.4)
<LOD 3.3
(2.7 - 3.9)
7.7
(6.8 - 8.5)
20
(15 - 26)
2 290 17.93 3.1
(2.5 - 3.8)
<LOD 3.4
(2.7 - 4.2)
7.1
(5.7 - 8.5)
19E
(9.9 - 28)

F Data is too unreliable to be published.

 
Table 14.4.1.3: Dimethylphosphate (DMP) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table c50 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c50 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c50 footnotes

Table c50 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c50 footnote a referrer

Table c50 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c50 footnote b referrer

Table c50 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c50 footnote c referrer

Males, Total 3-79 years
1Table c50 footnote c . . . . . . .
2 1280 13.59 3.3
(2.8 - 3.8)
<LOD 3.4
(2.8 - 4.0)
7.3
(6.0 - 8.6)
26
(21 - 31)
Males, 6-11 years
1 524 18.13 3.4
(2.7 - 4.4)
<LOD 3.8
(2.6 - 5.0)
11
(9.2 - 13)
31
(22 - 41)
2 262 13.36 5.8
(4.3 - 7.9)
F 5.6
(3.7 - 7.5)
14E
(7.3 - 20)
F
Males, 12-19 years
1 503 17.69 3.4
(2.6 - 4.4)
<LOD 3.7
(2.7 - 4.6)
9.9
(8.4 - 11)
25
(23 - 28)
2 256 10.16 3.5
(3.0 - 4.0)
<LOD 3.8
(3.0 - 4.6)
7.4
(6.0 - 8.9)
29E
(11 - 48)
Males, 20-39 years
1 511 22.70 2.5
(2.1 - 3.0)
<LOD 2.9E
(1.8 - 4.1)
6.3
(5.4 - 7.2)
F
2 166 22.29 3.0
(2.2 - 4.2)
<LOD 3.0E
(1.8 - 4.1)
F X
Males, 40-59 years
1 577 25.13 2.7
(2.0 - 3.6)
<LOD 3.0E
(1.7 - 4.3)
7.1
(4.9 - 9.2)
27E
(15 - 38)
2 194 17.01 2.8E
(1.9 - 4.3)
<LOD 2.8E
(1.7 - 3.9)
6.5E
(3.9 - 9.2)
X
Males, 60-79 years
1 538 14.31 3.3
(2.5 - 4.3)
<LOD 3.5
(2.6 - 4.3)
8.3
(6.7 - 10)
24
(18 - 31)
2 142 18.31 3.1
(2.2 - 4.3)
<LOD 3.7E
(2.3 - 5.0)
6.8
(5.3 - 8.2)
X
Females, Total 3-79 years
1Table c50 footnote c . . . . . . .
2 1276 13.56 3.4
(2.9 - 4.0)
<LOD 3.6
(2.8 - 4.5)
7.4
(6.3 - 8.6)
24
(17 - 31)
Females, 6-11 years
1 504 16.87 4.0
(3.0 - 5.2)
<LOD 4.7
(3.6 - 5.9)
11
(7.7 - 14)
28
(21 - 36)
2 254 7.09 6.4
(5.3 - 7.6)
1.5E
(<LOD - 2.1)
6.5
(4.7 - 8.3)
13
(9.8 - 16)
41E
(26 - 56)
Females, 12-19 years
1 477 13.63 4.2
(3.3 - 5.4)
<LOD 4.3
(3.2 - 5.4)
10
(8.0 - 12)
38E
(23 - 53)
2 256 11.33 4.3
(3.1 - 5.9)
<LOD 4.6
(3.0 - 6.3)
9.5E
(5.9 - 13)
31E
(15 - 47)
Females, 20-39 years
1 651 23.35 2.6
(2.1 - 3.4)
<LOD 3.0
(2.3 - 3.6)
6.2
(4.8 - 7.5)
29E
(17 - 41)
2 190 22.11 3.2E
(2.1 - 4.8)
<LOD 3.9E
(2.4 - 5.4)
7.5E
(4.6 - 10)
X
Females, 40-59 years
1 644 27.33 2.3
(1.7 - 3.1)
<LOD F 6.5
(4.6 - 8.3)
21
(16 - 26)
2 166 22.29 2.9
(2.1 - 4.0)
<LOD 2.8E
(1.0 - 4.5)
5.7
(4.0 - 7.4)
X
Females, 60-79 years
1 538 20.07 2.6
(2.2 - 3.1)
<LOD 3.0
(2.3 - 3.6)
6.7
(5.4 - 7.9)
16E
(10 - 23)
2 148 17.57 3.0
(2.4 - 3.9)
<LOD 3.2
(2.3 - 4.0)
7.4E
(4.4 - 10)
X
 
Table 14.4.1.4: Dimethylphosphate (DMP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c51 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c51 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c51 footnotes

Table c51 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c51 footnote a referrer

Table c51 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c51 footnote b referrer

Total, 6-79 years
1 5453 20.32 3.4
(2.9 - 4.0)
<LOD 3.5
(3.0 - 4.1)
7.6
(6.5 - 8.7)
24
(20 - 28)
2 2025 15.26 3.1
(2.8 - 3.5)
<LOD 3.0
(2.6 - 3.4)
6.8
(6.1 - 7.5)
22
(17 - 27)
Males, 6-79 years
1 2644 19.74 2.9
(2.4 - 3.4)
<LOD 2.9
(2.4 - 3.4)
6.4
(5.5 - 7.3)
19
(15 - 23)
2 1017 15.44 2.6
(2.3 - 3.0)
<LOD 2.5
(2.1 - 2.8)
5.4
(4.2 - 6.6)
20
(16 - 25)
Females, 6-79 years
1 2809 20.86 4.1
(3.5 - 4.8)
<LOD 4.2
(3.5 - 5.0)
8.9
(7.6 - 10)
27
(23 - 31)
2 1008 15.08 3.7
(3.1 - 4.5)
<LOD 3.3
(2.7 - 4.0)
8.0
(6.8 - 9.2)
28
(19 - 37)
 
Table 14.4.1.5: Dimethylphosphate (DMP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c52 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c52 footnotes

Table c52 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c52 footnote a referrer

Table c52 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c52 footnote b referrer

Total, 3-79 years
1Table c52 footnote b . . . . . . .
2 2546 13.63 3.3
(2.9 - 3.7)
<LOD 3.2
(2.8 - 3.5)
7.0
(6.3 - 7.7)
25
(19 - 31)
3-5 years
1Table c52 footnote b . . . . . . .
2 521 7.29 12
(9.8 - 14)
2.6
(1.9 - 3.3)
12
(8.8 - 16)
22
(16 - 28)
100E
(40 - 170)
6-11 years
1 1025 17.56 5.7
(5.0 - 6.6)
<LOD 6.3
(5.0 - 7.5)
14
(13 - 16)
40
(36 - 45)
2 514 10.31 6.9
(6.0 - 8.0)
1.6
(<LOD - 1.9)
7.2
(6.0 - 8.4)
15
(11 - 18)
52E
(22 - 83)
12-19 years
1 978 15.75 3.3
(2.8 - 4.0)
<LOD 3.7
(2.9 - 4.4)
7.8
(6.9 - 8.8)
20
(15 - 24)
2 510 10.78 2.9
(2.5 - 3.4)
<LOD 2.8
(2.3 - 3.3)
6.0
(4.3 - 7.7)
18E
(9.9 - 27)
20-39 years
1 1158 23.14 2.9
(2.5 - 3.4)
<LOD 2.9
(2.4 - 3.4)
6.1
(5.1 - 7.0)
22E
(13 - 30)
2 354 22.32 2.7
(2.1 - 3.4)
<LOD 2.5
(1.8 - 3.1)
5.5
(3.8 - 7.2)
23
(16 - 31)
40-59 years
1 1216 26.40 3.2
(2.6 - 4.0)
<LOD 3.4
(2.6 - 4.1)
7.1
(5.8 - 8.4)
24
(15 - 32)
2 358 19.55 2.9
(2.4 - 3.5)
<LOD 2.8
(2.3 - 3.2)
5.4E
(3.3 - 7.5)
17E
(7.7 - 26)
60-79 years
1 1076 17.19 4.2
(3.5 - 5.0)
<LOD 4.3
(3.6 - 5.0)
9.4
(8.2 - 11)
23
(18 - 27)
2 289 17.99 3.6
(2.9 - 4.4)
<LOD 3.8
(2.8 - 4.7)
7.6
(6.2 - 9.0)
19
(14 - 24)
 
Table 14.4.1.6: Dimethylphosphate (DMP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c53 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c53 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c53 footnotes

Table c53 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c53 footnote a referrer

Table c53 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c53 footnote b referrer

Table c53 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c53 footnote c referrer

Males, Total 3-79 years
1Table c53 footnote c . . . . . . .
2 1276 13.64 2.8
(2.5 - 3.1)
<LOD 2.5
(2.2 - 2.9)
6.0
(4.9 - 7.0)
21
(17 - 25)
Males, 6-11 years
1 522 18.20 5.3
(4.4 - 6.3)
<LOD 5.6
(3.7 - 7.6)
13
(10 - 16)
40
(33 - 46)
2 261 13.41 6.6
(5.1 - 8.6)
<LOD
(<LOD - 2.0)
6.9
(5.0 - 8.7)
16E
(9.1 - 24)
62E
(<LOD - 99)
Males, 12-19 years
1 502 17.73 2.9
(2.3 - 3.6)
<LOD 3.4
(2.5 - 4.3)
7.3
(6.0 - 8.6)
16
(12 - 20)
2 255 10.20 2.5
(2.1 - 2.8)
<LOD 2.4
(2.0 - 2.8)
5.1
(3.6 - 6.7)
16E
(9.2 - 23)
Males, 20-39 years
1 509 22.79 2.3
(2.0 - 2.8)
<LOD 2.3
(1.9 - 2.6)
4.7
(3.9 - 5.5)
14E
(<LOD - 22)
2 165 22.42 2.2
(1.7 - 2.8)
<LOD 2.0
(1.4 - 2.7)
4.8E
(<LOD - 6.6)
X
Males, 40-59 years
1 573 25.31 2.7
(2.0 - 3.5)
<LOD 2.9
(1.9 - 3.9)
5.8
(4.5 - 7.1)
19
(13 - 24)
2 194 17.01 2.4
(1.9 - 3.2)
<LOD 2.4
(1.8 - 3.0)
4.1E
(2.0 - 6.2)
X
Males, 60-79 years
1 538 14.31 3.6
(2.9 - 4.4)
<LOD 3.7
(2.7 - 4.7)
8.2
(6.6 - 9.8)
20
(14 - 27)
2 142 18.31 2.9
(2.2 - 3.8)
<LOD 3.5E
(2.0 - 5.0)
6.4
(5.3 - 7.5)
X
Females, Total 3-79 years
1Table c53 footnote c . . . . . . .
2 1270 13.62 3.8
(3.2 - 4.6)
<LOD 3.4
(2.6 - 4.2)
8.5
(7.3 - 9.7)
28
(20 - 37)
Females, 6-11 years
1 503 16.90 6.3
(5.2 - 7.6)
<LOD 7.2
(5.1 - 9.3)
15
(13 - 16)
42
(33 - 50)
2 253 7.11 7.3
(6.2 - 8.6)
1.7E
(<LOD - 2.5)
7.4
(5.4 - 9.4)
14
(11 - 17)
F
Females, 12-19 years
1 476 13.66 3.9
(3.2 - 4.7)
<LOD 4.0
(2.8 - 5.1)
8.6
(7.2 - 9.9)
24
(17 - 31)
2 255 11.37 3.5
(2.7 - 4.6)
<LOD 3.3
(2.4 - 4.3)
7.5
(4.8 - 10)
24E
(9.7 - 39)
Females, 20-39 years
1 649 23.42 3.6
(2.9 - 4.4)
<LOD 3.9
(3.1 - 4.7)
7.5
(6.0 - 9.0)
26E
(15 - 36)
2 189 22.22 3.2E
(2.0 - 5.1)
<LOD 3.2E
(1.9 - 4.5)
6.7E
(3.3 - 10)
X
Females, 40-59 years
1 643 27.37 3.9
(3.2 - 4.8)
<LOD 4.0
(<LOD - 5.1)
8.4
(6.3 - 10)
28E
(18 - 39)
2 164 22.56 3.5
(2.7 - 4.4)
<LOD 3.2
(2.3 - 4.1)
7.2E
(4.3 - 10)
X
Females, 60-79 years
1 538 20.07 4.8
(4.0 - 5.8)
<LOD 4.8
(3.9 - 5.7)
10
(9.0 - 12)
24
(19 - 30)
2 147 17.69 4.3
(3.3 - 5.5)
<LOD 4.4E
(1.7 - 7.0)
8.6
(5.8 - 11)
X
 
Table 14.4.2.1: Dimethylthiophosphate (DMTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c54 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c54 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c54 footnotes

Table c54 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c54 footnote a referrer

Table c54 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c54 footnote b referrer

Total, 6-79 years
1 5474 30.76 2.0
(1.7 - 2.4)
<LOD 2.0E
(1.1 - 2.8)
6.9
(5.6 - 8.3)
40
(37 - 43)
2 2035 18.03 2.6
(2.2 - 3.1)
<LOD 2.8
(2.1 - 3.4)
7.4E
(4.6 - 10)
37
(27 - 46)
Males, 6-79 years
1 2659 30.24 2.1
(1.8 - 2.4)
<LOD 2.0
(1.5 - 2.6)
6.6
(5.2 - 7.9)
40
(36 - 44)
2 1021 18.32 2.4
(2.0 - 2.9)
<LOD 2.3
(1.7 - 2.8)
6.4
(4.3 - 8.4)
36E
(17 - 56)
Females, 6-79 years
1 2815 31.26 2.0
(1.5 - 2.6)
<LOD 1.8E
(0.63 - 3.0)
7.2
(5.4 - 9.0)
39
(30 - 49)
2 1014 17.75 2.8
(2.3 - 3.6)
<LOD 3.2
(2.3 - 4.1)
9.4E
(5.7 - 13)
37
(28 - 45)
 
Table 14.4.2.2: Dimethylthiophosphate (DMTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c55 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c55 footnotes

Table c55 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c55 footnote a referrer

Table c55 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c55 footnote b referrer

Total, 3-79 years
1Table c55 footnote b . . . . . . .
2 2559 15.87 2.7
(2.3 - 3.2)
<LOD 2.8
(2.2 - 3.5)
8.1
(5.4 - 11)
37
(27 - 47)
3-5 years
1Table c55 footnote b . . . . . . .
2 524 7.44 6.3
(5.1 - 7.8)
0.72
(<LOD - 0.97)
6.4
(4.5 - 8.3)
18
(13 - 23)
89
(60 - 120)
6-11 years
1 1029 27.89 2.5
(1.9 - 3.2)
<LOD 2.5E
(1.4 - 3.5)
10
(7.2 - 13)
54
(45 - 64)
2 516 11.82 5.0
(4.2 - 6.0)
0.64
(<LOD - 0.80)
5.3
(3.7 - 6.9)
14
(9.8 - 18)
66E
(31 - 100)
12-19 years
1 980 27.65 2.3
(1.8 - 2.8)
<LOD 2.1
(1.4 - 2.8)
8.1
(6.0 - 10)
44
(30 - 58)
2 512 16.21 2.6
(2.1 - 3.3)
<LOD 2.7
(2.0 - 3.3)
7.7
(5.0 - 10)
36E
(22 - 50)
20-39 years
1 1163 34.48 1.8
(1.3 - 2.4)
<LOD 1.6E
(<LOD - 2.6)
5.7E
(3.6 - 7.7)
36E
(19 - 53)
2 356 23.60 2.4
(1.8 - 3.2)
<LOD 2.7
(1.8 - 3.7)
6.2E
(3.1 - 9.2)
29E
(17 - 41)
40-59 years
1 1223 36.22 1.8
(1.5 - 2.2)
<LOD 1.4E
(<LOD - 2.3)
6.2
(4.5 - 7.9)
38
(27 - 49)
2 360 21.94 2.4
(1.8 - 3.2)
<LOD 2.2E
(1.2 - 3.1)
F F
60-79 years
1 1079 26.14 2.6
(2.2 - 3.2)
<LOD 3.0
(2.1 - 3.8)
9.0
(6.6 - 11)
40
(35 - 45)
2 291 20.62 2.8
(2.1 - 3.8)
<LOD 3.3E
(2.1 - 4.6)
8.8E
(5.5 - 12)
44E
(20 - 68)
 
Table 14.4.2.3: Dimethylthiophosphate (DMTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c56 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c56 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c56 footnotes

Table c56 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c56 footnote a referrer

Table c56 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c56 footnote b referrer

Table c56 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c56 footnote c referrer

Males, Total 3-79 years
1Table c56 footnote c . . . . . . .
2 1281 16.00 2.5
(2.1 - 3.0)
<LOD 2.4
(1.8 - 3.0)
6.7
(4.3 - 9.1)
37E
(17 - 57)
Males, 6-11 years
1 525 29.33 2.5
(1.8 - 3.5)
<LOD 2.3E
(0.95 - 3.7)
12E
(6.0 - 18)
55
(39 - 72)
2 262 14.50 4.6
(3.4 - 6.2)
0.62E
(<LOD - 0.95)
4.3E
(2.7 - 5.9)
10E
(4.7 - 16)
F
Males, 12-19 years
1 503 28.03 2.2
(1.7 - 2.7)
<LOD 2.0E
(1.1 - 2.9)
8.1
(5.4 - 11)
39
(28 - 49)
2 256 15.63 2.4
(1.8 - 3.1)
<LOD 2.3E
(1.3 - 3.4)
6.2
(4.4 - 8.0)
22
(14 - 30)
Males, 20-39 years
1 512 34.38 1.8
(1.4 - 2.3)
<LOD 1.6E
(0.81 - 2.4)
5.1E
(2.7 - 7.5)
39E
(15 - 63)
2 167 25.75 2.2E
(1.4 - 3.5)
<LOD 1.8E
(<LOD - 3.1)
F X
Males, 40-59 years
1 578 34.60 1.9
(1.5 - 2.4)
<LOD 1.9E
(1.1 - 2.7)
6.1
(4.1 - 8.0)
33E
(19 - 47)
2 194 19.07 2.4E
(1.5 - 3.7)
<LOD 1.9E
(<LOD - 3.2)
F X
Males, 60-79 years
1 541 24.58 2.7
(2.1 - 3.5)
<LOD 3.0E
(1.8 - 4.1)
9.2E
(4.8 - 13)
43
(35 - 50)
2 142 20.42 2.4E
(1.5 - 3.9)
<LOD 2.7E
(1.4 - 4.1)
6.7E
(3.2 - 10)
X
Females, Total 3-79 years
1Table c56 footnote c . . . . . . .
2 1278 15.73 2.9
(2.3 - 3.6)
<LOD 3.2
(2.4 - 4.1)
9.5E
(6.0 - 13)
37
(29 - 45)
Females, 6-11 years
1 504 26.39 2.5
(1.9 - 3.4)
<LOD 2.6E
(1.1 - 4.2)
9.4
(6.9 - 12)
54
(43 - 66)
2 254 9.06 5.5
(4.1 - 7.4)
0.66E
(<LOD - 0.91)
6.0E
(3.2 - 8.8)
16
(13 - 20)
66E
(29 - 100)
Females, 12-19 years
1 477 27.25 2.3
(1.6 - 3.4)
<LOD 2.3E
(1.0 - 3.6)
8.1
(5.3 - 11)
55E
(23 - 86)
2 256 16.80 2.9
(2.1 - 4.1)
<LOD 2.7E
(1.6 - 3.8)
9.6E
(5.5 - 14)
43E
(26 - 59)
Females, 20-39 years
1 651 34.56 1.8E
(1.2 - 2.6)
<LOD F 6.1
(3.9 - 8.4)
34E
(10 - 58)
2 189 21.69 2.6E
(1.7 - 4.0)
<LOD 3.3E
(2.1 - 4.5)
5.9E
(2.8 - 9.1)
X
Females, 40-59 years
1 645 37.67 1.7
(1.3 - 2.2)
<LOD F 6.6E
(3.8 - 9.3)
44E
(21 - 66)
2 166 25.30 2.5E
(1.6 - 3.9)
<LOD 2.6E
(1.3 - 3.9)
F X
Females, 60-79 years
1 538 27.70 2.6
(2.0 - 3.2)
<LOD 3.0
(2.1 - 3.9)
8.9
(6.0 - 12)
34
(26 - 43)
2 149 20.81 3.2
(2.2 - 4.5)
<LOD 3.6E
(1.5 - 5.7)
F X
 
Table 14.4.2.4: Dimethylthiophosphate (DMTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c57 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c57 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c57 footnotes

Table c57 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c57 footnote a referrer

Table c57 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c57 footnote b referrer

Total, 6-79 years
1 5460 30.84 2.5
(2.1 - 2.9)
<LOD 2.1
(1.6 - 2.5)
8.0
(6.6 - 9.4)
45
(38 - 52)
2 2026 18.11 2.6
(2.2 - 3.0)
<LOD 2.5
(1.9 - 3.0)
7.5
(6.0 - 8.9)
34
(29 - 40)
Males, 6-79 years
1 2650 30.34 2.1
(1.8 - 2.3)
<LOD 1.8
(1.5 - 2.2)
6.2
(4.9 - 7.6)
34
(24 - 43)
2 1018 18.37 2.0
(1.7 - 2.4)
<LOD 1.9
(1.4 - 2.4)
6.1
(4.7 - 7.5)
24
(16 - 32)
Females, 6-79 years
1 2810 31.32 3.0
(2.4 - 3.7)
<LOD 2.5
(1.8 - 3.2)
9.5
(7.8 - 11)
51
(43 - 60)
2 1008 17.86 3.2
(2.5 - 4.0)
<LOD 3.1E
(2.0 - 4.2)
9.4
(7.0 - 12)
35
(27 - 43)
 
Table 14.4.2.5: Dimethylthiophosphate (DMTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c58 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c58 footnotes

Table c58 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c58 footnote a referrer

Table c58 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c58 footnote b referrer

Total, 3-79 years
1Table c58 footnote b . . . . . . .
2 2549 15.93 2.7
(2.3 - 3.1)
<LOD 2.5
(1.9 - 3.2)
7.8
(6.0 - 9.5)
35
(31 - 38)
3-5 years
1Table c58 footnote b . . . . . . .
2 523 7.46 11
(9.1 - 13)
1.5
(<LOD - 1.9)
11
(8.2 - 14)
33
(24 - 41)
110
(89 - 140)
6-11 years
1 1026 27.97 3.9
(3.2 - 4.8)
<LOD 3.7
(2.7 - 4.7)
14
(10 - 17)
70
(52 - 88)
2 514 11.87 5.7
(4.7 - 7.0)
0.84
(<LOD - 0.99)
5.9E
(3.4 - 8.4)
16E
(10 - 23)
90E
(29 - 150)
12-19 years
1 978 27.71 2.0
(1.6 - 2.4)
<LOD 2.0
(1.6 - 2.3)
6.2
(4.6 - 7.9)
30
(23 - 36)
2 510 16.27 2.0
(1.6 - 2.5)
<LOD 1.7
(1.1 - 2.3)
5.7
(4.6 - 6.7)
25E
(12 - 38)
20-39 years
1 1159 34.60 2.0
(1.6 - 2.6)
<LOD 1.8
(<LOD - 2.2)
5.8
(3.9 - 7.6)
34E
(18 - 51)
2 354 23.73 2.1
(1.6 - 2.7)
<LOD 2.1
(1.5 - 2.7)
6.5
(4.2 - 8.7)
33E
(17 - 49)
40-59 years
1 1218 36.37 2.3
(2.0 - 2.7)
<LOD 1.9
(<LOD - 2.4)
7.5
(5.6 - 9.3)
45
(37 - 54)
2 358 22.07 2.5
(1.9 - 3.2)
<LOD 2.4E
(1.4 - 3.5)
7.3E
(3.7 - 11)
30E
(18 - 41)
60-79 years
1 1079 26.14 3.7
(3.1 - 4.4)
<LOD 3.8
(2.7 - 4.9)
13
(10 - 15)
53
(40 - 67)
2 290 20.69 3.3
(2.4 - 4.4)
<LOD 3.5E
(2.2 - 4.9)
11E
(6.0 - 17)
F
 
Table 14.4.2.6: Dimethylthiophosphate (DMTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c59 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c59 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c59 footnotes

Table c59 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c59 footnote a referrer

Table c59 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c59 footnote b referrer

Table c59 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c59 footnote c referrer

Males, Total 3-79 years
1Table c59 footnote c . . . . . . .
2 1277 16.05 2.2
(1.8 - 2.6)
<LOD 2.0
(1.4 - 2.5)
6.6
(5.3 - 7.9)
29E
(19 - 40)
Males, 6-11 years
1 523 29.45 3.8
(2.8 - 5.2)
<LOD 3.3E
(1.7 - 5.0)
15E
(9.6 - 21)
63E
(38 - 89)
2 261 14.56 5.2
(3.8 - 7.3)
0.79E
(<LOD - 1.1)
4.7E
(2.4 - 7.0)
14E
(6.9 - 21)
F
Males, 12-19 years
1 502 28.09 1.9
(1.5 - 2.3)
<LOD 1.8
(1.3 - 2.3)
5.5
(3.5 - 7.4)
28
(21 - 36)
2 255 15.69 1.7
(1.3 - 2.2)
<LOD 1.6E
(0.96 - 2.2)
5.1
(3.7 - 6.6)
19E
(9.1 - 28)
Males, 20-39 years
1 510 34.51 1.7
(1.4 - 2.1)
<LOD 1.5
(1.2 - 1.8)
4.7E
(3.0 - 6.5)
F
2 166 25.9 1.6E
(1.1 - 2.4)
<LOD 1.6
(<LOD - 1.9)
F X
Males, 40-59 years
1 574 34.84 1.9
(1.5 - 2.4)
<LOD 1.7
(1.2 - 2.2)
5.3E
(2.4 - 8.2)
23E
(14 - 33)
2 194 19.07 2.0
(1.4 - 2.9)
<LOD 1.9E
(<LOD - 2.9)
5.9E
(<LOD - 9.1)
X
Males, 60-79 years
1 541 24.58 2.9
(2.4 - 3.5)
<LOD 3.1
(2.1 - 4.0)
10E
(5.5 - 15)
41
(26 - 56)
2 142 20.42 2.3
(1.6 - 3.3)
<LOD 2.5E
(1.3 - 3.7)
6.7E
(3.2 - 10)
X
Females, Total 3-79 years
1Table c59 footnote c . . . . . . .
2 1272 15.80 3.3
(2.6 - 4.2)
<LOD 3.4
(2.3 - 4.5)
9.5
(7.1 - 12)
38
(25 - 50)
Females, 6-11 years
1 503 26.44 4.0
(3.2 - 5.1)
<LOD 4.1
(2.7 - 5.5)
13
(9.3 - 17)
80
(53 - 110)
2 253 9.09 6.4
(4.8 - 8.4)
0.90
(<LOD - 1.2)
6.7E
(3.3 - 10)
18
(12 - 25)
F
Females, 12-19 years
1 476 27.31 2.2
(1.6 - 2.8)
<LOD 2.0
(1.7 - 2.4)
7.2
(5.3 - 9.1)
F
2 255 16.86 2.4
(1.8 - 3.3)
<LOD 2.1E
(1.2 - 3.0)
6.2
(4.0 - 8.3)
38E
(13 - 62)
Females, 20-39 years
1 649 34.67 2.5
(1.8 - 3.4)
<LOD 2.0
(<LOD - 2.7)
7.0E
(4.0 - 10)
F
2 188 21.81 2.6E
(1.7 - 4.0)
<LOD 2.7E
(1.2 - 4.3)
6.8
(4.6 - 9.0)
X
Females, 40-59 years
1 644 37.73 2.8
(2.3 - 3.5)
<LOD 2.2E
(<LOD - 3.0)
9.2
(7.2 - 11)
50E
(19 - 81)
2 164 25.61 3.0
(2.1 - 4.3)
<LOD 2.7E
(0.90 - 4.5)
10E
(3.8 - 16)
X
Females, 60-79 years
1 538 27.70 4.7
(3.8 - 5.9)
<LOD 4.8E
(2.6 - 6.9)
14
(9.8 - 18)
54
(43 - 66)
2 148 20.95 4.5E
(3.0 - 6.7)
<LOD 6.1E
(2.9 - 9.3)
18E
(11 - 24)
X
 
Table 14.4.3.1: Dimethyldithiophosphate (DMDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c60 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c60 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c60 footnotes

Table c60 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c60 footnote a referrer

Table c60 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c60 footnote b referrer

Total, 6-79 years
1 5475 61.95 -- <LOD <LOD 0.63
(0.42 - 0.85)
5.9
(5.0 - 6.8)
2 2014 51.64 -- <LOD <LOD 0.85
(0.66 - 1.0)
6.3
(4.8 - 7.8)
Males, 6-79 years
1 2659 62.24 -- <LOD <LOD 0.59
(0.39 - 0.79)
5.5
(4.4 - 6.7)
2 1011 54.60 -- <LOD <LOD 0.70
(0.47 - 0.93)
5.4E
(3.4 - 7.4)
Females, 6-79 years
1 2816 61.68 -- <LOD <LOD 0.67E
(0.40 - 0.95)
6.6
(4.8 - 8.4)
2 1003 48.65 -- <LOD 0.33
(<LOD - 0.42)
0.93E
(0.55 - 1.3)
7.6
(5.0 - 10)
 
Table 14.4.3.2: Dimethyldithiophosphate (DMDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c61 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c61 footnotes

Table c61 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c61 footnote a referrer

Table c61 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c61 footnote b referrer

Total, 3-79 years
1Table c61 footnote b . . . . . . .
2 2537 49.11 -- <LOD <LOD 0.87
(0.68 - 1.1)
6.5
(5.2 - 7.8)
3-5 years
1Table c61 footnote b . . . . . . .
2 523 39.39 0.85
(0.68 - 1.1)
<LOD 0.57E
(0.32 - 0.83)
2.3E
(1.1 - 3.4)
18E
(9.6 - 26)
6-11 years
1 1029 57.92 -- <LOD <LOD 0.88
(0.61 - 1.2)
7.2
(4.8 - 9.5)
2 512 45.12 -- <LOD 0.49E
(<LOD - 0.75)
1.3
(0.88 - 1.7)
9.3E
(5.6 - 13)
12-19 years
1 980 62.04 -- <LOD <LOD 0.56E
(0.30 - 0.82)
7.0
(4.9 - 9.1)
2 512 50.59 -- <LOD <LOD 0.68
(0.48 - 0.88)
F
20-39 years
1 1163 66.98 -- <LOD <LOD 0.52E
(0.29 - 0.74)
4.6E
(2.4 - 6.7)
2 357 60.22 -- <LOD <LOD 0.59
(0.41 - 0.77)
4.4E
(2.3 - 6.4)
40-59 years
1 1223 66.56 -- <LOD <LOD 0.56E
(0.33 - 0.79)
5.8
(4.3 - 7.4)
2 353 58.64 -- <LOD <LOD 0.86E
(0.32 - 1.4)
6.1E
(2.7 - 9.5)
60-79 years
1 1080 55.09 -- <LOD <LOD 1.0
(0.67 - 1.3)
7.5
(5.0 - 9.9)
2 280 45.71 -- <LOD F 1.1E
(0.34 - 1.9)
9.5E
(3.7 - 15)
 
Table 14.4.3.3: Dimethyldithiophosphate (DMDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c62 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c62 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c62 footnotes

Table c62 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c62 footnote a referrer

Table c62 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c62 footnote b referrer

Table c62 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c62 footnote c referrer

Males, Total 3-79 years
1Table c62 footnote c . . . . . . .
2 1271 51.30 -- <LOD <LOD 0.73
(0.49 - 0.98)
5.7
(3.8 - 7.6)
Males, 6-11 years
1 525 59.62 -- <LOD <LOD 0.82E
(0.38 - 1.3)
8.5E
(4.0 - 13)
2 262 50.38 -- <LOD F 1.2
(0.82 - 1.7)
F
Males, 12-19 years
1 503 62.03 -- <LOD <LOD 0.53E
(0.27 - 0.79)
F
2 256 53.52 -- <LOD <LOD 0.54E
(0.30 - 0.78)
F
Males, 20-39 years
1 512 67.97 -- <LOD <LOD 0.50E
(0.26 - 0.74)
4.5E
(2.0 - 7.0)
2 167 67.07 -- <LOD <LOD F X
Males, 40-59 years
1 578 66.26 -- <LOD <LOD 0.60E
(0.36 - 0.84)
5.7
(4.4 - 6.9)
2 189 57.14 -- <LOD <LOD F X
Males, 60-79 years
1 541 55.27 -- <LOD <LOD 0.99
(0.71 - 1.3)
7.4E
(2.6 - 12)
2 137 45.99 -- <LOD F 0.92E
(0.34 - 1.5)
X
Females, Total 3-79 years
1Table c62 footnote c . . . . . . .
2 1266 46.92 -- <LOD 0.33
(<LOD - 0.42)
0.96E
(0.58 - 1.3)
7.8
(5.5 - 10)
Females, 6-11 years
1 504 56.15 -- <LOD <LOD 0.96E
(0.57 - 1.4)
5.7E
(3.2 - 8.2)
2 250 39.60 0.68
(0.50 - 0.92)
<LOD 0.50E
(<LOD - 0.75)
1.4E
(0.65 - 2.1)
8.8E
(4.8 - 13)
Females, 12-19 years
1 477 62.05 -- <LOD <LOD 0.66E
(0.21 - 1.1)
7.9E
(3.2 - 13)
2 256 47.66 -- <LOD <LODE
(<LOD - 0.34)
0.86E
(0.53 - 1.2)
7.2E
(2.3 - 12)
Females, 20-39 years
1 651 66.21 -- <LOD <LOD 0.57E
(0.33 - 0.80)
F
2 190 54.21 -- <LOD 0.30
(<LOD - 0.40)
0.59E
(0.37 - 0.81)
X
Females, 40-59 years
1 645 66.82 -- <LOD <LOD 0.51E
(0.15 - 0.87)
F
2 164 60.37 -- <LOD F F X
Females, 60-79 years
1 539 54.92 -- <LOD <LOD 1.0E
(0.41 - 1.7)
7.3E
(3.9 - 11)
2 143 45.45 -- <LOD 0.54E
(<LOD - 0.81)
2.0E
(0.79 - 3.2)
X
 
Table 14.4.3.4: Dimethyldithiophosphate (DMDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c63 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c63 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c63 footnotes

Table c63 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c63 footnote a referrer

Table c63 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c63 footnote b referrer

Total, 6-79 years
1 5461 62.11 -- <LOD <LOD 0.62E
(0.38 - 0.87)
7.3
(5.6 - 9.1)
2 2005 51.87 -- <LOD <LOD 0.95
(0.76 - 1.1)
6.8
(4.7 - 8.9)
Males, 6-79 years
1 2650 62.45 -- <LOD <LOD 0.47
(0.31 - 0.64)
5.5E
(2.8 - 8.3)
2 1008 54.76 -- <LOD <LOD 0.58E
(0.37 - 0.79)
3.8E
(2.4 - 5.2)
Females, 6-79 years
1 2811 61.79 -- <LOD <LOD 0.78E
(0.42 - 1.1)
8.7
(6.4 - 11)
2 997 48.95 -- <LOD 0.40
(<LOD - 0.54)
1.2
(0.82 - 1.5)
9.1
(7.0 - 11)
 
Table 14.4.3.5: Dimethyldithiophosphate (DMDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c64 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c64 footnotes

Table c64 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c64 footnote a referrer

Table c64 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c64 footnote b referrer

Total, 3-79 years
1Table c64 footnote b . . . . . . .
2 2527 49.31 -- <LOD <LOD 0.96
(0.80 - 1.1)
7.3
(5.3 - 9.3)
3-5 years
1Table c64 footnote b . . . . . . .
2 522 39.46 1.3
(1.0 - 1.7)
<LOD 0.96
(0.70 - 1.2)
3.7E
(1.9 - 5.5)
27E
(16 - 38)
6-11 years
1 1026 58.09 -- <LOD <LOD 1.1E
(0.63 - 1.5)
11
(8.5 - 13)
2 510 45.29 -- <LOD 0.52E
(<LOD - 0.72)
1.5E
(0.93 - 2.1)
9.7E
(5.2 - 14)
12-19 years
1 978 62.17 -- <LOD <LOD 0.43E
(0.19 - 0.67)
5.3E
(3.2 - 7.4)
2 510 50.78 -- <LOD <LOD 0.49
(0.33 - 0.65)
F
20-39 years
1 1159 67.21 -- <LOD <LOD 0.46E
(0.27 - 0.64)
4.8E
(2.6 - 6.9)
2 355 60.56 -- <LOD <LOD 0.55E
(0.17 - 0.93)
4.2E
(1.3 - 7.0)
40-59 years
1 1218 66.83 -- <LOD <LOD 0.54E
(0.29 - 0.79)
8.7
(6.1 - 11)
2 351 58.97 -- <LOD <LOD 0.95E
(0.51 - 1.4)
6.7E
(3.1 - 10)
60-79 years
1 1080 55.09 -- <LOD <LOD 1.4
(0.94 - 1.8)
9.3E
(3.8 - 15)
2 279 45.88 -- <LOD 0.51E
(<LOD - 0.71)
1.8
(1.2 - 2.4)
10E
(6.0 - 15)
 
Table 14.4.3.6: Dimethyldithiophosphate (DMDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c65 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c65 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c65 footnotes

Table c65 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c65 footnote a referrer

Table c65 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c65 footnote b referrer

Table c65 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c65 footnote c referrer

Males, Total 3-79 years
1Table c65 footnote c . . . . . . .
2 1267 51.46 -- <LOD <LOD 0.64E
(0.40 - 0.88)
4.5
(3.0 - 5.9)
Males, 6-11 years
1 523 59.85 -- <LOD <LOD F 12E
(7.1 - 16)
2 261 50.57 -- <LOD 0.52E
(<LOD - 0.89)
1.5E
(0.78 - 2.2)
F
Males, 12-19 years
1 502 62.15 -- <LOD <LOD 0.34E
(0.14 - 0.53)
F
2 255 53.73 -- <LOD <LOD 0.33E
(0.19 - 0.48)
F
Males, 20-39 years
1 510 68.24 -- <LOD <LOD 0.42E
(0.24 - 0.60)
F
2 166 67.47 -- <LOD <LOD F X
Males, 40-59 years
1 574 66.72 -- <LOD <LOD 0.46E
(0.27 - 0.66)
5.1E
(1.4 - 8.8)
2 189 57.14 -- <LOD <LOD 0.57E
(<LOD - 0.80)
X
Males, 60-79 years
1 541 55.27 -- <LOD <LOD 0.95
(0.64 - 1.3)
8.1E
(3.4 - 13)
2 137 45.99 -- <LOD <LOD
(<LOD - 0.45)
0.95E
(0.40 - 1.5)
X
Females, Total 3-79 years
1Table c65 footnote c . . . . . . .
2 1260 47.14 -- <LOD 0.41
(<LOD - 0.55)
1.3
(0.93 - 1.7)
9.4
(7.3 - 11)
Females, 6-11 years
1 503 56.26 -- <LOD <LOD 1.2E
(0.66 - 1.7)
9.9
(7.4 - 12)
2 249 39.76 0.71
(0.51 - 0.97)
<LOD 0.52E
(<LOD - 0.74)
1.5E
(0.70 - 2.2)
10E
(5.6 - 15)
Females, 12-19 years
1 476 62.18 -- <LOD <LOD 0.63E
(0.22 - 1.0)
F
2 255 47.84 -- <LOD <LOD
(<LOD - 0.40)
0.79E
(0.42 - 1.2)
4.3E
(1.5 - 7.1)
Females, 20-39 years
1 649 66.41 -- <LOD <LOD 0.57E
(0.29 - 0.86)
F
2 189 54.50 -- <LOD 0.29
(<LOD - 0.38)
0.83E
(0.50 - 1.2)
X
Females, 40-59 years
1 644 66.93 -- <LOD <LOD 0.68E
(0.31 - 1.0)
11
(<LOD - 14)
2 162 61.11 -- <LOD 0.57E
(<LOD - 0.87)
1.3E
(<LOD - 2.0)
X
Females, 60-79 years
1 539 54.92 -- <LOD <LOD 2.0E
(0.92 - 3.0)
11E
(3.2 - 19)
2 142 45.77 -- <LOD 0.83E
(<LOD - 1.3)
F X
 
Table 14.4.4.1: Diethylphosphate (DEP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c66 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c66 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c66 footnotes

Table c66 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c66 footnote a referrer

Table c66 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c66 footnote b referrer

Total, 6-79 years
1 5475 20.40 2.0
(1.7 - 2.4)
<LOD 2.3
(2.0 - 2.6)
4.7
(4.4 - 5.0)
12
(11 - 14)
2 2033 14.85 2.7
(2.5 - 3.0)
<LOD 2.7
(2.4 - 3.0)
5.6
(5.0 - 6.3)
18
(16 - 21)
Males, 6-79 years
1 2659 19.03 2.1
(1.8 - 2.5)
<LOD 2.4
(2.0 - 2.7)
4.8
(4.5 - 5.1)
13
(11 - 15)
2 1019 13.54 2.8
(2.5 - 3.2)
<LOD 2.9
(2.4 - 3.4)
5.6
(4.5 - 6.8)
17E
(9.8 - 25)
Females, 6-79 years
1 2816 21.70 2.0
(1.6 - 2.4)
<LOD 2.2
(1.9 - 2.5)
4.6
(4.2 - 5.0)
12
(9.9 - 14)
2 1014 16.17 2.7
(2.3 - 3.1)
<LOD 2.6
(2.2 - 2.9)
5.6
(4.7 - 6.6)
19
(15 - 22)
 
Table 14.4.4.2: Diethylphosphate (DEP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c67 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c67 footnotes

Table c67 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c67 footnote a referrer

Table c67 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c67 footnote b referrer

Total, 3-79 years
1Table c67 footnote b . . . . . . .
2 2556 13.58 2.8
(2.6 - 3.1)
<LOD 2.8
(2.5 - 3.1)
5.7
(5.1 - 6.4)
19
(16 - 21)
3-5 years
1Table c67 footnote b . . . . . . .
2 523 8.60 4.9
(4.1 - 5.9)
1.2
(<LOD - 1.6)
5.1
(4.1 - 6.1)
9.3
(7.2 - 12)
29E
(9.9 - 48)
6-11 years
1 1029 17.88 2.6
(1.9 - 3.5)
<LOD 3.0
(2.3 - 3.6)
6.4
(5.5 - 7.3)
17
(14 - 20)
2 515 11.26 4.1
(3.7 - 4.7)
1.1
(<LOD - 1.3)
4.0
(3.5 - 4.5)
8.1
(6.6 - 9.7)
23E
(12 - 33)
12-19 years
1 980 17.35 2.7
(2.1 - 3.4)
<LOD 3.1
(2.4 - 3.7)
6.2
(5.2 - 7.2)
18
(14 - 22)
2 512 12.30 3.4
(3.0 - 3.9)
<LOD 3.1
(2.6 - 3.7)
7.4
(5.8 - 8.9)
23E
(14 - 31)
20-39 years
1 1163 22.96 1.9
(1.5 - 2.4)
<LOD 2.1
(1.8 - 2.5)
4.1
(3.6 - 4.6)
12
(8.6 - 14)
2 357 16.81 2.7
(2.3 - 3.2)
<LOD 2.6
(2.2 - 3.0)
5.3
(4.3 - 6.2)
20E
(7.9 - 32)
40-59 years
1 1223 25.35 1.8
(1.5 - 2.2)
<LOD 2.1
(1.8 - 2.4)
4.5
(3.8 - 5.1)
11
(8.2 - 13)
2 360 19.72 2.5
(2.0 - 3.1)
<LOD 2.5
(1.9 - 3.1)
5.0
(3.5 - 6.4)
16E
(8.6 - 23)
60-79 years
1 1080 17.22 2.2
(1.9 - 2.5)
<LOD 2.3
(2.0 - 2.7)
4.8
(4.3 - 5.3)
12
(9.8 - 13)
2 289 17.30 2.6
(2.0 - 3.3)
<LOD 2.6
(1.9 - 3.4)
5.6
(3.9 - 7.4)
16
(12 - 21)
 
Table 14.4.4.3: Diethylphosphate (DEP) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group Table c68 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c68 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c68 footnotes

Table c68 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c68 footnote a referrer

Table c68 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c68 footnote b referrer

Table c68 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c68 footnote c referrer

Males, Total 3-79 years
1Table c68 footnote c . . . . . . .
2 1279 12.51 2.9
(2.6 - 3.3)
<LOD 2.9
(2.5 - 3.4)
5.7
(4.6 - 6.9)
18E
(11 - 26)
Males, 6-11 years
1 525 18.67 2.6
(1.8 - 3.7)
<LOD 2.9
(1.9 - 3.8)
6.5
(5.3 - 7.7)
18
(12 - 24)
2 261 10.73 4.0
(3.2 - 4.9)
1.2
(<LOD - 1.5)
3.6
(2.5 - 4.7)
7.5
(5.1 - 9.9)
21E
(7.1 - 34)
Males, 12-19 years
1 503 16.30 2.6
(2.1 - 3.4)
<LOD 2.9
(2.1 - 3.7)
6.1
(4.9 - 7.4)
17
(13 - 21)
2 256 12.50 3.3
(2.6 - 4.2)
<LOD 3.0
(1.9 - 4.0)
7.0
(4.8 - 9.3)
F
Males, 20-39 years
1 512 22.66 1.8
(1.4 - 2.4)
<LOD 2.1
(1.7 - 2.6)
4.1
(3.3 - 4.8)
11
(7.8 - 15)
2 167 13.77 2.9
(2.1 - 4.2)
<LOD 2.8
(2.1 - 3.5)
5.6
(4.0 - 7.2)
X
Males, 40-59 years
1 578 21.45 2.0
(1.6 - 2.5)
<LOD 2.3
(1.8 - 2.7)
4.6
(3.8 - 5.5)
12
(7.6 - 16)
2 194 18.04 2.3
(1.8 - 3.1)
<LOD 2.6E
(1.5 - 3.7)
4.7E
(2.8 - 6.6)
X
Males, 60-79 years
1 541 15.90 2.4
(2.0 - 3.0)
<LOD 2.6
(1.9 - 3.3)
5.3
(4.3 - 6.3)
13
(9.2 - 16)
2 141 14.18 3.0
(2.1 - 4.3)
<LOD 3.1E
(1.9 - 4.3)
5.9E
(3.1 - 8.6)
X
Females, Total 3-79 years
1Table c68 footnote c . . . . . . .
2 1277 14.64 2.7
(2.3 - 3.1)
<LOD 2.6
(2.2 - 2.9)
5.7
(4.8 - 6.7)
19
(15 - 23)
Females, 6-11 years
1 504 17.06 2.6
(1.9 - 3.5)
<LOD 3.0
(2.4 - 3.7)
6.3
(5.2 - 7.4)
16
(13 - 20)
2 254 11.81 4.3
(3.4 - 5.6)
<LOD 4.4
(3.3 - 5.4)
9.0
(6.8 - 11)
F
Females, 12-19 years
1 477 18.45 2.7
(2.1 - 3.6)
<LOD 3.2
(2.4 - 3.9)
6.4
(5.1 - 7.7)
21
(15 - 28)
2 256 12.11 3.5
(2.8 - 4.4)
1.0E
(<LOD - 1.5)
3.2
(2.4 - 3.9)
7.5
(5.3 - 9.8)
21E
(13 - 29)
Females, 20-39 years
1 651 23.20 2.0
(1.5 - 2.6)
<LOD 2.1
(1.8 - 2.5)
4.2
(3.7 - 4.7)
12E
(7.6 - 17)
2 190 19.47 2.5
(1.9 - 3.3)
<LOD 2.5
(1.7 - 3.3)
5.2
(3.7 - 6.6)
X
Females, 40-59 years
1 645 28.84 1.7
(1.3 - 2.1)
<LOD 2.0
(1.7 - 2.3)
4.2
(3.3 - 5.0)
10
(8.0 - 12)
2 166 21.69 2.6
(1.9 - 3.7)
<LOD 2.5
(1.7 - 3.2)
5.5E
(3.5 - 7.5)
X
Females, 60-79 years
1 539 18.55 1.9
(1.7 - 2.2)
<LOD 2.1
(1.9 - 2.3)
4.1
(3.3 - 4.9)
10
(8.3 - 13)
2 148 20.27 2.2
(1.6 - 3.0)
<LOD 2.1E
(1.3 - 2.8)
5.5E
(2.5 - 8.5)
X
 
Table 14.4.4.4: Diethylphosphate (DEP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c69 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c69 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c69 footnotes

Table c69 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c69 footnote a referrer

Table c69 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c69 footnote b referrer

Total, 6-79 years
1 5461 20.45 2.4
(2.0 - 2.8)
<LOD 2.6
(2.3 - 3.0)
5.2
(4.8 - 5.5)
12
(11 - 13)
2 2024 14.92 2.6
(2.4 - 2.8)
<LOD 2.5
(2.3 - 2.8)
4.6
(4.2 - 5.0)
14
(12 - 16)
Males, 6-79 years
1 2650 19.09 2.0
(1.7 - 2.4)
<LOD 2.3
(2.0 - 2.6)
4.4
(4.1 - 4.7)
11
(10 - 12)
2 1016 13.58 2.3
(2.0 - 2.6)
<LOD 2.2
(1.9 - 2.5)
4.2
(3.5 - 4.9)
14
(9.7 - 18)
Females, 6-79 years
1 2811 21.74 2.8
(2.4 - 3.3)
<LOD 3.1
(2.5 - 3.6)
5.8
(5.3 - 6.3)
14
(12 - 16)
2 1008 16.27 3.0
(2.6 - 3.4)
<LOD 2.8
(2.4 - 3.3)
5.0
(4.0 - 6.0)
14
(10 - 18)
 
Table 14.4.4.5: Diethylphosphate (DEP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c70 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c70 footnotes

Table c70 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c70 footnote a referrer

Table c70 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c70 footnote b referrer

Total, 3-79 years
1Table c70 footnote b . . . . . . .
2 2546 13.63 2.7
(2.5 - 3.0)
<LOD 2.6
(2.3 - 2.9)
4.8
(4.4 - 5.2)
15
(12 - 17)
3-5 years
1Table c70 footnote b . . . . . . .
2 522 8.62 8.5
(7.3 - 9.9)
2.6
(<LOD - 3.3)
8.6
(7.2 - 10)
15
(10 - 19)
44
(33 - 56)
6-11 years
1 1026 17.93 3.9
(3.0 - 5.0)
<LOD 4.0
(3.3 - 4.8)
8.4
(7.0 - 9.8)
24
(20 - 29)
2 513 11.31 4.8
(4.3 - 5.3)
1.6
(<LOD - 1.8)
4.6
(3.9 - 5.2)
8.8
(7.0 - 11)
25E
(12 - 38)
12-19 years
1 978 17.38 2.3
(1.8 - 2.9)
<LOD 2.5
(2.0 - 3.0)
5.1
(4.6 - 5.6)
12
(10 - 13)
2 510 12.35 2.6
(2.3 - 3.0)
<LOD 2.5
(2.0 - 3.0)
4.7
(3.9 - 5.5)
16E
(9.9 - 21)
20-39 years
1 1159 23.04 2.1
(1.7 - 2.6)
<LOD 2.2
(1.9 - 2.6)
4.3
(3.6 - 4.9)
10
(8.3 - 12)
2 355 16.90 2.2
(1.9 - 2.7)
<LOD 2.1
(1.5 - 2.7)
3.7
(3.2 - 4.3)
F
40-59 years
1 1218 25.45 2.3
(1.9 - 2.7)
<LOD 2.5
(2.2 - 2.9)
5.0
(4.5 - 5.5)
11
(10 - 13)
2 358 19.83 2.5
(2.2 - 2.9)
<LOD 2.4
(2.0 - 2.8)
4.6
(3.7 - 5.5)
11
(7.6 - 15)
60-79 years
1 1080 17.22 3.0
(2.6 - 3.4)
<LOD 3.4
(3.1 - 3.8)
6.2
(5.5 - 6.9)
13
(11 - 16)
2 288 17.36 3.0
(2.5 - 3.7)
<LOD 2.9
(2.2 - 3.6)
5.4
(4.0 - 6.7)
14
(10 - 17)
 
Table 14.4.4.6: Diethylphosphate (DEP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c71 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c71 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c71 footnotes

Table c71 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c71 footnote a referrer

Table c71 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c71 footnote b referrer

Table c71 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c71 footnote c referrer

Males, Total 3-79 years
1Table c71 footnote c . . . . . . .
2 1275 12.55 2.4
(2.1 - 2.7)
<LOD 2.2
(1.8 - 2.6)
4.6
(3.9 - 5.3)
14
(9.6 - 19)
Males, 6-11 years
1 523 18.74 3.8
(2.9 - 5.0)
<LOD 4.1
(3.0 - 5.2)
8.2
(7.0 - 9.4)
25
(17 - 32)
2 260 10.77 4.5
(3.7 - 5.5)
1.5
(<LOD - 1.9)
4.6
(3.2 - 6.0)
8.2E
(5.1 - 11)
22
(17 - 28)
Males, 12-19 years
1 502 16.33 2.2
(1.8 - 2.7)
<LOD 2.5
(2.0 - 2.9)
5.1
(4.5 - 5.6)
11
(8.4 - 14)
2 255 12.55 2.3
(1.9 - 2.9)
<LOD 1.9E
(1.1 - 2.8)
4.4E
(2.6 - 6.2)
17E
(9.6 - 25)
Males, 20-39 years
1 510 22.75 1.6
(1.3 - 2.1)
<LOD 1.8
(1.4 - 2.1)
3.3
(2.7 - 4.0)
7.6
(6.4 - 8.8)
2 166 13.86 2.0
(1.4 - 2.8)
<LOD 1.7E
(1.0 - 2.4)
3.2
(2.2 - 4.3)
X
Males, 40-59 years
1 574 21.60 1.9
(1.6 - 2.3)
<LOD 2.2
(1.8 - 2.6)
4.0
(3.3 - 4.7)
11
(9.8 - 12)
2 194 18.04 2.0
(1.6 - 2.5)
<LOD 2.0
(1.5 - 2.4)
3.6
(2.6 - 4.7)
X
Males, 60-79 years
1 541 15.90 2.5
(2.1 - 3.0)
<LOD 3.0
(2.5 - 3.4)
5.2
(4.5 - 6.0)
11
(8.6 - 13)
2 141 14.18 2.8
(2.3 - 3.6)
<LOD 2.9
(2.3 - 3.5)
4.9
(3.9 - 5.8)
X
Females, Total 3-79 years
1Table c71 footnote c . . . . . . .
2 1271 14.71 3.1
(2.7 - 3.5)
<LOD 2.9
(2.5 - 3.4)
5.4
(4.3 - 6.5)
15
(11 - 19)
Females, 6-11 years
1 503 17.10 3.9
(3.0 - 5.1)
<LOD 4.0
(3.4 - 4.6)
8.7
(6.4 - 11)
24
(19 - 30)
2 253 11.86 5.1
(4.1 - 6.2)
<LOD 4.4
(3.0 - 5.8)
9.1
(6.8 - 11)
28E
(13 - 44)
Females, 12-19 years
1 476 18.49 2.4
(1.9 - 3.1)
<LOD 2.6
(1.9 - 3.3)
5.1
(4.3 - 6.0)
12
(11 - 14)
2 255 12.16 2.9
(2.3 - 3.6)
1.0
(<LOD - 1.3)
2.9
(2.0 - 3.8)
4.9
(4.1 - 5.7)
13E
(7.8 - 18)
Females, 20-39 years
1 649 23.27 2.6
(2.1 - 3.3)
<LOD 2.7
(2.2 - 3.2)
5.3
(4.5 - 6.1)
12
(9.2 - 16)
2 189 19.58 2.5
(1.9 - 3.3)
<LOD 2.5
(1.6 - 3.3)
4.0
(3.1 - 4.9)
X
Females, 40-59 years
1 644 28.88 2.7
(2.2 - 3.2)
<LOD 3.1
(2.4 - 3.8)
5.5
(4.8 - 6.1)
12
(9.5 - 14)
2 164 21.95 3.1
(2.6 - 3.8)
<LOD 2.8
(2.3 - 3.3)
5.7
(4.1 - 7.4)
X
Females, 60-79 years
1 539 18.55 3.5
(3.0 - 4.0)
<LOD 4.0
(3.3 - 4.7)
7.1
(5.9 - 8.2)
17E
(9.3 - 25)
2 147 20.41 3.2
(2.4 - 4.2)
<LOD 2.6E
(1.5 - 3.7)
6.1E
(2.6 - 9.5)
X
 
Table 14.4.5.1: Diethylthiophosphate (DETP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c72 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c72 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c72 footnotes

Table c72 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c72 footnote a referrer

Table c72 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c72 footnote b referrer

Total, 6-79 years
1 5474 59.77 -- <LOD <LOD 0.98
(0.82 - 1.1)
4.0
(3.1 - 4.8)
2 1999 25.46 0.65
(0.59 - 0.71)
<LOD 0.59
(0.49 - 0.69)
1.1
(1.0 - 1.3)
5.2E
(3.0 - 7.4)
Males, 6-79 years
1 2658 58.50 -- <LOD <LOD 0.98
(0.82 - 1.1)
4.0
(2.8 - 5.2)
2 1006 25.05 0.62
(0.55 - 0.70)
<LOD 0.56
(0.46 - 0.66)
1.1
(0.92 - 1.3)
3.5E
(1.7 - 5.3)
Females, 6-79 years
1 2816 60.97 -- <LOD <LOD 0.99
(0.81 - 1.2)
3.8
(2.9 - 4.8)
2 993 25.88 0.68
(0.58 - 0.79)
<LOD 0.61
(0.45 - 0.77)
1.2
(0.96 - 1.4)
F
 
Table 14.4.5.2: Diethylthiophosphate (DETP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c73 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c73 footnotes

Table c73 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c73 footnote a referrer

Table c73 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c73 footnote b referrer

Total, 3-79 years
1Table c73 footnote b . . . . . . .
2 2511 23.26 0.66
(0.60 - 0.72)
<LOD 0.60
(0.51 - 0.70)
1.2
(1.0 - 1.3)
5.3E
(3.2 - 7.4)
3-5 years
1Table c73 footnote b . . . . . . .
2 512 14.65 1.0
(0.92 - 1.2)
<LOD 1.0
(0.91 - 1.1)
1.9
(1.5 - 2.4)
6.7E
(3.4 - 10)
6-11 years
1 1029 54.71 -- <LOD <LOD 1.1
(0.89 - 1.3)
4.8
(3.9 - 5.7)
2 508 22.05 0.85
(0.74 - 0.98)
<LOD 0.78
(0.68 - 0.88)
1.5
(1.2 - 1.9)
F
12-19 years
1 979 54.55 -- <LOD <LOD 1.1
(0.84 - 1.4)
4.1
(3.1 - 5.1)
2 504 22.82 0.67
(0.57 - 0.78)
<LOD 0.59
(0.47 - 0.71)
1.3
(1.0 - 1.6)
4.1E
(2.5 - 5.7)
20-39 years
1 1163 64.14 -- <LOD <LOD 0.88
(0.69 - 1.1)
2.9
(1.9 - 3.8)
2 349 29.23 0.57
(0.48 - 0.69)
<LOD 0.47E
(<LOD - 0.64)
1.0
(0.81 - 1.2)
5.4E
(1.6 - 9.1)
40-59 years
1 1223 65.74 -- <LOD <LOD 0.98
(0.72 - 1.2)
4.6E
(2.8 - 6.5)
2 352 28.41 0.66
(0.53 - 0.83)
<LOD 0.65
(0.46 - 0.84)
1.1
(0.84 - 1.5)
F
60-79 years
1 1080 57.87 -- <LOD <LOD 1.1
(0.88 - 1.2)
4.1
(3.5 - 4.7)
2 286 27.97 0.67
(0.55 - 0.83)
<LOD 0.59
(0.41 - 0.76)
1.2
(0.90 - 1.6)
F
 
Table 14.4.5.3: Diethylthiophosphate (DETP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c74 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c74 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c74 footnotes

Table c74 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c74 footnote a referrer

Table c74 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c74 footnote b referrer

Table c74 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c74 footnote c referrer

Males, Total 3-79 years
1Table c74 footnote c . . . . . . .
2 1261 22.84 0.63
(0.56 - 0.71)
<LOD 0.58
(0.49 - 0.67)
1.1
(0.96 - 1.3)
3.5E
(1.6 - 5.5)
Males, 6-11 years
1 525 53.90 -- <LOD <LOD 1.2
(0.84 - 1.5)
5.4E
(2.5 - 8.2)
2 260 22.69 0.80
(0.68 - 0.95)
<LOD 0.81
(0.65 - 0.97)
1.5
(1.1 - 2.0)
4.0
(3.1 - 5.0)
Males, 12-19 years
1 502 54.38 -- <LOD <LOD 1.1
(0.82 - 1.3)
4.4E
(2.2 - 6.5)
2 250 23.20 0.68
(0.56 - 0.82)
<LOD 0.64
(0.45 - 0.83)
1.3
(0.90 - 1.7)
3.5E
(2.1 - 4.9)
Males, 20-39 years
1 512 64.06 -- <LOD <LOD 0.86
(0.60 - 1.1)
2.8E
(1.4 - 4.2)
2 164 27.44 0.51
(0.38 - 0.66)
<LOD 0.44E
(<LOD - 0.61)
0.79E
(0.37 - 1.2)
X
Males, 40-59 years
1 578 65.92 -- <LOD <LOD 0.96
(0.71 - 1.2)
4.6E
(2.7 - 6.5)
2 192 27.60 0.63
(0.46 - 0.87)
<LOD 0.57E
(0.32 - 0.81)
1.2E
(0.57 - 1.8)
X
Males, 60-79 years
1 541 53.60 -- <LOD <LOD 1.2
(0.98 - 1.5)
4.1E
(1.9 - 6.4)
2 140 26.43 0.73
(0.51 - 1.0)
<LOD 0.67
(0.48 - 0.86)
F X
Females, Total 3-79 years
1Table c74 footnote c . . . . . . .
2 1250 23.68 0.68
(0.59 - 0.79)
<LOD 0.61
(0.46 - 0.76)
1.2
(0.97 - 1.4)
5.6E
(1.6 - 9.5)
Females, 6-11 years
1 504 55.56 -- <LOD <LOD 1.1
(0.69 - 1.4)
4.3
(3.2 - 5.3)
2 248 21.37 0.91
(0.68 - 1.2)
<LOD 0.77
(0.62 - 0.92)
F F
Females, 12-19 years
1 477 54.72 -- <LOD <LOD 1.2
(0.80 - 1.6)
4.0
(3.2 - 4.7)
2 254 22.44 0.66
(0.52 - 0.83)
<LOD 0.55
(0.39 - 0.71)
1.3E
(0.78 - 1.8)
5.0E
(1.6 - 8.5)
Females, 20-39 years
1 651 64.21 -- <LOD <LOD 0.94
(0.70 - 1.2)
3.5E
(2.0 - 4.9)
2 185 30.81 0.65
(0.49 - 0.86)
<LOD 0.60E
(0.31 - 0.90)
1.1E
(0.39 - 1.8)
X
Females, 40-59 years
1 645 65.58 -- <LOD <LOD 0.99
(0.69 - 1.3)
5.2E
(2.5 - 7.9)
2 160 29.38 0.70
(0.51 - 0.95)
<LOD 0.66
(0.43 - 0.90)
1.1
(0.79 - 1.5)
X
Females, 60-79 years
1 539 62.15 -- <LOD <LOD 0.94
(0.77 - 1.1)
3.6
(2.4 - 4.7)
2 146 29.45 0.63
(0.45 - 0.88)
<LOD 0.49E
(<LOD - 0.72)
1.3E
(0.73 - 1.8)
X
 
Table 14.4.5.4: Diethylthiophosphate (DETP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c75 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c75 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c75 footnotes

Table c75 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c75 footnote a referrer

Table c75 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c75 footnote b referrer

Total, 6-79 years
1 5460 59.93 -- <LOD <LOD 0.85
(0.62 - 1.1)
4.2
(3.4 - 5.1)
2 1990 25.58 0.58
(0.52 - 0.65)
<LOD 0.55
(0.45 - 0.65)
1.2
(1.1 - 1.4)
3.9
(3.2 - 4.5)
Males, 6-79 years
1 2649 58.70 -- <LOD <LOD 0.72
(0.53 - 0.92)
3.5
(2.9 - 4.0)
2 1003 25.12 0.48
(0.42 - 0.55)
<LOD 0.41
(0.31 - 0.52)
0.96
(0.81 - 1.1)
3.0E
(1.8 - 4.2)
Females, 6-79 years
1 2811 61.08 -- <LOD <LOD 0.99
(0.72 - 1.3)
4.7
(3.8 - 5.7)
2 987 26.04 0.71
(0.59 - 0.86)
<LOD 0.68
(0.54 - 0.83)
1.4
(1.1 - 1.7)
4.8E
(2.4 - 7.3)
 
Table 14.4.5.5: Diethylthiophosphate (DETP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c76 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c76 footnotes

Table c76 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c76 footnote a referrer

Table c76 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c76 footnote b referrer

Total, 3-79 years
1Table c76 footnote b . . . . . . .
2 2501 23.35 0.61
(0.55 - 0.67)
<LOD 0.59
(0.50 - 0.68)
1.3
(1.2 - 1.4)
4.2
(3.6 - 4.8)
3-5 years
1Table c76 footnote b . . . . . . .
2 511 14.68 1.7
(1.5 - 2.0)
<LOD 1.7
(1.4 - 2.0)
3.5
(2.9 - 4.1)
9.6E
(5.1 - 14)
6-11 years
1 1026 54.87 -- <LOD <LOD 1.3E
(0.72 - 1.8)
6.4
(4.3 - 8.4)
2 506 22.13 0.93
(0.78 - 1.1)
<LOD 0.89
(0.75 - 1.0)
1.9
(1.5 - 2.3)
F
12-19 years
1 977 54.66 -- <LOD <LOD 0.78
(0.56 - 0.99)
3.1
(2.1 - 4.1)
2 502 22.91 0.47
(0.40 - 0.56)
<LOD 0.48
(0.37 - 0.59)
0.93
(0.77 - 1.1)
2.8E
(1.6 - 4.1)
20-39 years
1 1159 64.37 -- <LOD <LOD 0.67
(0.42 - 0.91)
3.0
(1.9 - 4.1)
2 347 29.39 0.46
(0.40 - 0.53)
<LOD 0.39
(<LOD - 0.49)
1.0
(0.85 - 1.2)
3.7E
(2.4 - 5.1)
40-59 years
1 1218 66.01 -- <LOD <LOD 0.77E
(0.40 - 1.1)
5.4E
(3.4 - 7.5)
2 350 28.57 0.62
(0.48 - 0.80)
<LOD 0.62
(0.45 - 0.80)
1.3E
(0.71 - 1.8)
4.0E
(<LOD - 6.2)
60-79 years
1 1080 57.87 -- <LOD <LOD 1.2
(0.93 - 1.4)
4.1
(2.7 - 5.4)
2 285 28.07 0.72
(0.58 - 0.88)
<LOD 0.69
(0.54 - 0.85)
1.4
(1.1 - 1.6)
F
 
Table 14.4.5.6: Diethylthiophosphate (DETP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c77 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c77 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c77 footnotes

Table c77 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c77 footnote a referrer

Table c77 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c77 footnote b referrer

Table c77 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c77 footnote c referrer

Males, Total 3-79 years
1Table c77 footnote c . . . . . . .
2 1257 22.91 0.50
(0.44 - 0.57)
<LOD 0.44
(0.33 - 0.55)
1.0
(0.83 - 1.2)
3.3
(2.2 - 4.5)
Males, 6-11 years
1 523 54.11 -- <LOD <LOD 1.3E
(0.60 - 2.0)
6.7E
(3.8 - 9.7)
2 259 22.78 0.86
(0.70 - 1.1)
<LOD 0.90
(0.58 - 1.2)
1.9
(1.4 - 2.4)
3.8
(3.3 - 4.3)
Males, 12-19 years
1 501 54.49 -- <LOD <LOD 0.67
(0.49 - 0.85)
3.0E
(0.91 - 5.1)
2 249 23.29 0.45
(0.37 - 0.55)
<LOD 0.48
(0.36 - 0.61)
0.81
(0.56 - 1.1)
F
Males, 20-39 years
1 510 64.31 -- <LOD <LOD 0.55E
(0.34 - 0.77)
2.0
(1.5 - 2.6)
2 163 27.61 0.34
(0.26 - 0.45)
<LOD 0.32
(<LOD - 0.42)
0.65E
(0.34 - 0.96)
X
Males, 40-59 years
1 574 66.38 -- <LOD <LOD 0.64E
(0.39 - 0.89)
3.7
(2.5 - 4.9)
2 192 27.60 0.50
(0.37 - 0.67)
<LOD 0.44E
(0.22 - 0.66)
0.98
(0.65 - 1.3)
X
Males, 60-79 years
1 541 53.60 -- <LOD <LOD 1.1
(0.82 - 1.3)
3.8E
(1.3 - 6.3)
2 140 26.43 0.64
(0.47 - 0.86)
<LOD 0.55
(0.37 - 0.74)
1.3E
(<LOD - 1.8)
X
Females, Total 3-79 years
1Table c77 footnote c . . . . . . .
2 1244 23.79 0.73
(0.61 - 0.88)
<LOD 0.69
(0.56 - 0.82)
1.5
(1.1 - 1.9)
5.2E
(2.9 - 7.6)
Females, 6-11 years
1 503 55.67 -- <LOD <LOD 1.3E
(0.55 - 2.0)
6.0E
(3.5 - 8.5)
2 247 21.46 1.0
(0.76 - 1.4)
<LOD 0.86
(0.69 - 1.0)
1.8E
(0.93 - 2.6)
F
Females, 12-19 years
1 476 54.83 -- <LOD <LOD 0.88
(0.59 - 1.2)
3.3
(2.3 - 4.2)
2 253 22.53 0.50
(0.40 - 0.62)
<LOD 0.48
(0.34 - 0.62)
0.98
(0.80 - 1.2)
3.0E
(1.5 - 4.5)
Females, 20-39 years
1 649 64.41 -- <LOD <LOD 0.92E
(0.51 - 1.3)
4.2
(2.8 - 5.6)
2 184 30.98 0.61
(0.47 - 0.80)
<LOD 0.60E
(0.33 - 0.87)
1.3E
(0.69 - 2.0)
X
Females, 40-59 years
1 644 65.68 -- <LOD <LOD 1.0E
(0.50 - 1.5)
7.1E
(4.0 - 10)
2 158 29.75 0.78E
(0.52 - 1.2)
<LOD 0.69E
(0.43 - 0.94)
1.5E
(0.62 - 2.5)
X
Females, 60-79 years
1 539 62.15 -- <LOD <LOD 1.2
(0.91 - 1.5)
4.5
(3.2 - 5.8)
2 145 29.66 0.80
(0.56 - 1.1)
<LOD 0.75E
(<LOD - 1.0)
1.4E
(0.67 - 2.0)
X
 
Table 14.4.6.1: Diethyldithiophosphate (DEDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c78 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c78 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c78 footnotes

Table c78 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c78 footnote a referrer

Table c78 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c78 footnote b referrer

Total, 6-79 years
1 5475 96.84 -- <LOD <LOD <LOD <LOD
2 2033 97.15 -- <LOD <LOD <LOD <LOD
Males, 6-79 years
1 2659 96.35 -- <LOD <LOD <LOD <LOD
2 1019 96.37 -- <LOD <LOD <LOD F
Females, 6-79 years
1 2816 97.30 -- <LOD <LOD <LOD <LOD
2 1014 97.93 -- <LOD <LOD <LOD <LOD
 
Table 14.4.6.2: Diethyldithiophosphate (DEDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c79 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c79 footnotes

Table c79 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c79 footnote a referrer

Table c79 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c79 footnote b referrer

Total, 3-79 years
1Table c79 footnote b . . . . . . .
2 2557 97.38 -- <LOD <LOD <LOD <LOD
3-5 years
1Table c79 footnote b . . . . . . .
2 524 98.28 -- <LOD <LOD <LOD <LOD
6-11 years
1 1029 96.21 -- <LOD <LOD <LOD <LOD
2 516 97.48 -- <LOD <LOD <LOD F
12-19 years
1 980 96.12 -- <LOD <LOD <LOD <LOD
2 511 97.06 -- <LOD <LOD <LOD <LOD
20-39 years
1 1163 97.08 -- <LOD <LOD <LOD <LOD
2 356 96.35 -- <LOD <LOD <LOD <LOD
40-59 years
1 1223 97.30 -- <LOD <LOD <LOD <LOD
2 360 97.22 -- <LOD <LOD <LOD <LOD
60-79 years
1 1080 97.31 -- <LOD <LOD <LOD <LOD
2 290 97.59 -- <LOD <LOD <LOD <LOD
 
Table 14.4.6.3: Diethyldithiophosphate (DEDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c80 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c80 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c80 footnotes

Table c80 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c80 footnote a referrer

Table c80 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c80 footnote b referrer

Table c80 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c80 footnote c referrer

Males, Total 3-79 years
1Table c80 footnote c . . . . . . .
2 1279 96.79 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
1 525 96.19 -- <LOD <LOD <LOD <LOD
2 262 97.33 -- <LOD <LOD <LOD F
Males, 12-19 years
1 503 95.83 -- <LOD <LOD <LOD <LOD
2 255 97.25 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
1 512 97.07 -- <LOD <LOD <LOD <LOD
2 167 94.61 -- <LOD <LOD <LOD X
Males, 40-59 years
1 578 96.89 -- <LOD <LOD <LOD <LOD
2 194 95.36 -- <LOD <LOD <LOD X
Males, 60-79 years
1 541 95.75 -- <LOD <LOD <LOD <LOD
2 141 96.45 -- <LOD <LOD <LOD X
Females, Total 3-79 years
1Table c80 footnote c . . . . . . .
2 1278 97.97 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
1 504 96.23 -- <LOD <LOD <LOD <LOD
2 254 97.64 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
1 477 96.44 -- <LOD <LOD <LOD <LOD
2 256 96.88 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
1 651 97.08 -- <LOD <LOD <LOD <LOD
2 189 97.88 -- <LOD <LOD <LOD X
Females, 40-59 years
1 645 97.67 -- <LOD <LOD <LOD <LOD
2 166 99.40 -- <LOD <LOD <LOD X
Females, 60-79 years
1 539 98.89 -- <LOD <LOD <LOD <LOD
2 149 98.66 -- <LOD <LOD <LOD X
 
Table 14.4.6.4: Diethyldithiophosphate (DEDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c81 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c81 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c81 footnotes

Table c81 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c81 footnote a referrer

Table c81 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c81 footnote b referrer

Total, 6-79 years
1 5461 97.09 -- <LOD <LOD <LOD <LOD
2 2024 97.58 -- <LOD <LOD <LOD <LOD
Males, 6-79 years
1 2650 96.68 -- <LOD <LOD <LOD <LOD
2 1016 96.65 -- <LOD <LOD <LOD 0.55
(<LOD - 0.73)
Females, 6-79 years
1 2811 97.47 -- <LOD <LOD <LOD <LOD
2 1008 98.51 -- <LOD <LOD <LOD <LOD
 
Table 14.4.6.5: Diethyldithiophosphate (DEDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c82 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c82 footnotes

Table c82 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c82 footnote a referrer

Table c82 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c82 footnote b referrer

Total, 3-79 years
1Table c82 footnote b . . . . . . .
2 2547 97.76 -- <LOD <LOD <LOD <LOD
3-5 years
1Table c82 footnote b . . . . . . .
2 523 98.47 -- <LOD <LOD <LOD <LOD
6-11 years
1 1026 96.49 -- <LOD <LOD <LOD <LOD
2 514 97.86 -- <LOD <LOD <LOD 0.73E
(<LOD - 1.2)
12-19 years
1 978 96.32 -- <LOD <LOD <LOD <LOD
2 509 97.45 -- <LOD <LOD <LOD <LOD
20-39 years
1 1159 97.41 -- <LOD <LOD <LOD <LOD
2 354 96.89 -- <LOD <LOD <LOD <LOD
40-59 years
1 1218 97.70 -- <LOD <LOD <LOD <LOD
2 358 97.77 -- <LOD <LOD <LOD <LOD
60-79 years
1 1080 97.31 -- <LOD <LOD <LOD <LOD
2 289 97.92 -- <LOD <LOD <LOD <LOD
 
Table 14.4.6.6: Diethyldithiophosphate (DEDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c83 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c83 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c83 footnotes

Table c83 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c83 footnote a referrer

Table c83 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c83 footnote b referrer

Table c83 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c83 footnote c referrer

Males, Total 3-79 years
1Table c83 footnote c . . . . . . .
2 1275 97.10 -- <LOD <LOD <LOD <LOD
Males, 6-11 years
1 523 96.56 -- <LOD <LOD <LOD <LOD
2 261 97.70 -- <LOD <LOD <LOD 0.71E
(<LOD - 1.1)
Males, 12-19 years
1 502 96.02 -- <LOD <LOD <LOD <LOD
2 254 97.64 -- <LOD <LOD <LOD <LOD
Males, 20-39 years
1 510 97.45 -- <LOD <LOD <LOD <LOD
2 166 95.18 -- <LOD <LOD <LOD X
Males, 40-59 years
1 574 97.56 -- <LOD <LOD <LOD <LOD
2 194 95.36 -- <LOD <LOD <LOD X
Males, 60-79 years
1 541 95.75 -- <LOD <LOD <LOD <LOD
2 141 96.45 -- <LOD <LOD <LOD X
Females, Total 3-79 years
1Table c83 footnote c . . . . . . .
2 1272 98.43 -- <LOD <LOD <LOD <LOD
Females, 6-11 years
1 503 96.42 -- <LOD <LOD <LOD <LOD
2 253 98.02 -- <LOD <LOD <LOD <LOD
Females, 12-19 years
1 476 96.64 -- <LOD <LOD <LOD <LOD
2 255 97.25 -- <LOD <LOD <LOD <LOD
Females, 20-39 years
1 649 97.38 -- <LOD <LOD <LOD <LOD
2 188 98.40 -- <LOD <LOD <LOD X
Females, 40-59 years
1 644 97.83 -- <LOD <LOD <LOD <LOD
2 164 100 -- <LOD <LOD <LOD X
Females, 60-79 years
1 539 98.89 -- <LOD <LOD <LOD <LOD
2 148 99.32 -- <LOD <LOD <LOD X
 
Table 14.5.1.1: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c84 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c84 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c84 footnotes

Table c84 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c84 footnote a referrer

Table c84 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c84 footnote b referrer

Total, 6-79 years
1 5224 56.45 -- <LOD <LOD 0.0099
(<LOD - 0.013)
0.076
(0.054 - 0.098)
2 2022 43.37 -- <LOD 0.0091
(0.0080 - 0.010)
0.018
(0.012 - 0.023)
0.11E
(0.035 - 0.18)
Males, 6-79 years
1 2529 54.49 -- <LOD <LOD 0.011
(<LOD - 0.015)
0.091E
(0.049 - 0.13)
2 1012 44.07 -- <LOD 0.0090
(<LOD - 0.011)
0.018
(0.012 - 0.024)
0.10E
(0.039 - 0.17)
Females, 6-79 years
1 2695 58.29 -- <LOD <LOD 0.0098
(0.0084 - 0.011)
0.058
(0.045 - 0.071)
2 1010 42.67 -- <LOD 0.0092
(0.0083 - 0.010)
0.018E
(0.010 - 0.026)
F
 
Table 14.5.1.2: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c85 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c85 footnotes

Table c85 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c85 footnote a referrer

Table c85 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c85 footnote b referrer

Total, 3-79 years
1Table c85 footnote b . . . . . . .
2 2539 44.70 -- <LOD 0.0091
(<LOD - 0.010)
0.018
(0.013 - 0.023)
0.11E
(0.040 - 0.17)
3-5 years
1Table c85 footnote b . . . . . . .
2 517 49.90 -- <LOD <LOD 0.015E
(<LOD - 0.023)
0.050
(0.032 - 0.067)
6-11 years
1 998 57.52 -- <LOD <LOD 0.0096
(0.0093 - 0.0098)
F
2 514 43.77 -- <LOD 0.0087
(<LOD - 0.011)
0.015E
(0.0091 - 0.020)
0.056E
(0.028 - 0.085)
12-19 years
1 947 49.10 -- <LOD F 0.011
(<LOD - 0.015)
0.060E
(0.017 - 0.10)
2 510 41.76 -- <LOD 0.0090
(<LOD - 0.011)
0.015
(0.011 - 0.019)
F
20-39 years
1 1100 54.82 -- <LOD <LOD 0.011E
(<LOD - 0.015)
0.089E
(0.030 - 0.15)
2 352 43.18 -- <LOD 0.0093
(<LOD - 0.012)
0.019E
(<LOD - 0.030)
0.11E
(0.033 - 0.19)
40-59 years
1 1161 59.09 -- <LOD <LOD 0.010E
(<LOD - 0.014)
0.079E
(0.048 - 0.11)
2 357 41.46 -- <LOD 0.0094
(0.0083 - 0.010)
0.026E
(0.011 - 0.040)
F
60-79 years
1 1018 61.00 -- <LOD <LOD 0.0095
(<LOD - 0.011)
0.069E
(0.021 - 0.12)
2 289 48.10 -- <LOD <LOD F F
 
Table 14.5.1.3: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c86 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c86 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c86 footnotes

Table c86 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c86 footnote a referrer

Table c86 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c86 footnote b referrer

Table c86 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c86 footnote c referrer

Males, Total 3-79 years
1Table c86 footnote c . . . . . . .
2 1268 44.16 -- <LOD 0.0090
(<LOD - 0.012)
0.018
(0.012 - 0.023)
0.10E
(0.044 - 0.16)
Males, 6-11 years
1 515 56.31 -- <LOD <LOD 0.0098
(0.0089 - 0.011)
0.053E
(0.022 - 0.084)
2 261 44.44 -- <LOD 0.0092
(<LOD - 0.011)
0.017E
(<LOD - 0.026)
F
Males, 12-19 years
1 485 47.22 -- <LOD 0.0083E
(<LOD - 0.011)
0.013
(0.0083 - 0.017)
0.061E
(0.032 - 0.091)
2 255 45.49 -- <LOD F 0.011E
(<LOD - 0.015)
0.040E
(0.023 - 0.056)
Males, 20-39 years
1 484 52.89 -- <LOD <LOD 0.014E
(<LOD - 0.021)
F
2 162 43.83 -- <LOD 0.0091E
(<LOD - 0.013)
0.017E
(0.0091 - 0.024)
X
Males, 40-59 years
1 541 57.30 -- <LOD <LOD 0.011E
(<LOD - 0.017)
0.10E
(0.047 - 0.16)
2 192 39.58 0.014
(0.0098 - 0.020)
<LOD 0.0094
(<LOD - 0.011)
0.030E
(0.012 - 0.049)
X
Males, 60-79 years
1 504 58.13 -- <LOD <LOD 0.0096
(<LOD - 0.011)
0.068E
(0.030 - 0.11)
2 142 47.18 -- <LOD <LOD 0.012E
(<LOD - 0.019)
X
Females, Total 3-79 years
1Table c86 footnote c . . . . . . .
2 1271 45.24 -- <LOD 0.0092
(0.0083 - 0.010)
0.018E
(0.011 - 0.025)
F
Females, 6-11 years
1 483 58.80 -- <LOD <LOD 0.0094
(0.0090 - 0.0098)
F
2 253 43.08 -- <LOD F 0.011E
(<LOD - 0.015)
0.046E
(0.029 - 0.063)
Females, 12-19 years
1 462 51.08 -- <LOD <LOD 0.0099
(<LOD - 0.013)
F
2 255 38.04 0.012
(0.0088 - 0.017)
<LOD 0.0094
(0.0085 - 0.010)
0.018E
(<LOD - 0.028)
F
Females, 20-39 years
1 616 56.33 -- <LOD <LOD 0.0098
(<LOD - 0.012)
0.066E
(0.035 - 0.098)
2 190 42.63 -- <LOD 0.0095
(<LOD - 0.011)
0.025E
(0.011 - 0.040)
X
Females, 40-59 years
1 620 60.65 -- <LOD <LOD 0.0099
(<LOD - 0.013)
0.057E
(0.034 - 0.079)
2 165 43.64 -- <LOD 0.0094
(<LOD - 0.011)
F X
Females, 60-79 years
1 514 63.81 -- <LOD <LOD 0.0094
(<LOD - 0.012)
F
2 147 48.98 -- <LOD <LOD F X
 
Table 14.5.1.4: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c87 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c87 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c87 footnotes

Table c87 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c87 footnote a referrer

Table c87 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c87 footnote b referrer

Total, 6-79 years
1 5210 56.60 -- <LOD <LOD 0.017
(<LOD - 0.020)
0.072E
(0.038 - 0.10)
2 2013 43.57 -- <LOD 0.0094
(0.0078 - 0.011)
0.019
(0.015 - 0.022)
F
Males, 6-79 years
1 2520 54.68 -- <LOD <LOD 0.014
(<LOD - 0.017)
F
2 1009 44.20 -- <LOD 0.0074
(<LOD - 0.0089)
0.016
(0.012 - 0.020)
F
Females, 6-79 years
1 2690 58.40 -- <LOD <LOD 0.020
(0.017 - 0.023)
0.072E
(0.043 - 0.10)
2 1004 42.93 -- <LOD 0.012
(0.0096 - 0.014)
0.021
(0.016 - 0.025)
F
 
Table 14.5.1.5: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c88 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c88 footnotes

Table c88 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c88 footnote a referrer

Table c88 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c88 footnote b referrer

Total, 3-79 years
1Table c88 footnote b . . . . . . .
2 2529 44.88 -- <LOD 0.0096
(<LOD - 0.011)
0.019
(0.016 - 0.022)
F
3-5 years
1Table c88 footnote b . . . . . . .
2 516 50.00 -- <LOD <LOD 0.028E
(<LOD - 0.040)
0.090E
(0.057 - 0.12)
6-11 years
1 995 57.69 -- <LOD <LOD 0.018
(0.015 - 0.020)
0.070E
(0.042 - 0.099)
2 512 43.95 -- <LOD 0.010
(<LOD - 0.012)
0.017
(0.011 - 0.022)
0.066E
(0.024 - 0.11)
12-19 years
1 945 49.21 -- <LOD <LOD
(<LOD - 0.0087)
0.013
(<LOD - 0.016)
0.045E
(0.016 - 0.074)
2 508 41.93 -- <LOD 0.0067
(<LOD - 0.0080)
0.012
(0.0096 - 0.015)
F
20-39 years
1 1096 55.02 -- <LOD <LOD 0.017
(<LOD - 0.021)
F
2 350 43.43 -- <LOD 0.0087E
(<LOD - 0.012)
0.018E
(<LOD - 0.027)
F
40-59 years
1 1156 59.34 -- <LOD <LOD 0.018
(<LOD - 0.022)
0.079E
(0.039 - 0.12)
2 355 41.69 -- <LOD 0.012
(0.0096 - 0.015)
0.022
(0.017 - 0.027)
F
60-79 years
1 1018 61.00 -- <LOD <LOD 0.018
(<LOD - 0.023)
0.095E
(0.026 - 0.16)
2 288 48.26 -- <LOD <LOD 0.018E
(<LOD - 0.029)
F
 
Table 14.5.1.6: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c89 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c89 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c89 footnotes

Table c89 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c89 footnote a referrer

Table c89 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c89 footnote b referrer

Table c89 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c89 footnote c referrer

Males, Total 3-79 years
1Table c89 footnote c . . . . . . .
2 1264 44.30 -- <LOD 0.0077
(<LOD - 0.0093)
0.017
(0.013 - 0.020)
F
Males, 6-11 years
1 513 56.53 -- <LOD <LOD 0.018
(0.014 - 0.022)
0.072E
(0.036 - 0.11)
2 260 44.62 -- <LOD 0.011
(<LOD - 0.014)
0.018E
(<LOD - 0.027)
F
Males, 12-19 years
1 484 47.31 -- <LOD 0.0080
(<LOD - 0.0096)
0.014
(0.011 - 0.018)
0.041
(0.031 - 0.051)
2 254 45.67 -- <LOD <LOD
(<LOD - 0.0068)
0.011
(<LOD - 0.014)
0.024E
(0.015 - 0.034)
Males, 20-39 years
1 482 53.11 -- <LOD <LOD 0.015E
(<LOD - 0.021)
F
2 161 44.10 -- <LOD 0.0055
(<LOD - 0.0067)
F X
Males, 40-59 years
1 537 57.73 -- <LOD <LOD 0.014
(<LOD - 0.016)
F
2 192 39.58 0.012
(0.0095 - 0.015)
<LOD 0.011
(<LOD - 0.014)
0.020
(0.015 - 0.026)
X
Males, 60-79 years
1 504 58.13 -- <LOD <LOD 0.013
(<LOD - 0.017)
0.058E
(0.034 - 0.082)
2 142 47.18 -- <LOD <LOD 0.016
(<LOD - 0.019)
X
Females, Total 3-79 years
1Table c89 footnote c . . . . . . .
2 1265 45.45 -- <LOD 0.012
(0.0097 - 0.014)
0.021
(0.017 - 0.025)
F
Females, 6-11 years
1 482 58.92 -- <LOD <LOD 0.017
(0.014 - 0.020)
0.063E
(<LOD - 0.10)
2 252 43.25 -- <LOD <LOD
(<LOD - 0.012)
0.015
(<LOD - 0.020)
0.056E
(0.034 - 0.077)
Females, 12-19 years
1 461 51.19 -- <LOD <LOD 0.012
(<LOD - 0.015)
F
2 254 38.19 0.010
(0.0079 - 0.013)
<LOD 0.0086
(0.0068 - 0.010)
0.017E
(<LOD - 0.024)
0.099E
(<LOD - 0.17)
Females, 20-39 years
1 614 56.51 -- <LOD <LOD 0.019
(<LOD - 0.024)
0.072E
(0.037 - 0.11)
2 189 42.86 -- <LOD 0.013
(<LOD - 0.017)
0.021E
(0.0060 - 0.036)
X
Females, 40-59 years
1 619 60.74 -- <LOD <LOD 0.022
(<LOD - 0.026)
0.070
(0.048 - 0.091)
2 163 44.17 -- <LOD 0.013
(<LOD - 0.016)
0.022E
(<LOD - 0.030)
X
Females, 60-79 years
1 514 63.81 -- <LOD <LOD 0.022
(<LOD - 0.030)
F
2 146 49.32 -- <LOD <LOD 0.021E
(<LOD - 0.030)
X
 
Table 14.5.2.1: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c90 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c90 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c90 footnotes

Table c90 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c90 footnote a referrer

Table c90 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c90 footnote b referrer

Total, 6-79 years
1 5022 50.36 -- <LOD <LOD 0.019
(0.014 - 0.025)
0.073
(0.060 - 0.087)
2 2013 37.75 0.012
(0.010 - 0.014)
<LOD 0.0094
(0.0082 - 0.011)
0.030
(0.025 - 0.036)
0.15E
(0.073 - 0.23)
Males, 6-79 years
1 2433 49.65 -- <LOD <LOD 0.020
(0.019 - 0.020)
0.074
(0.060 - 0.089)
2 1013 36.72 0.012
(0.010 - 0.015)
<LOD 0.0096
(0.0070 - 0.012)
0.034E
(0.021 - 0.046)
0.14E
(0.046 - 0.24)
Females, 6-79 years
1 2589 51.02 -- <LOD <LOD 0.019E
(0.0068 - 0.031)
0.072
(0.052 - 0.092)
2 1000 38.80 0.011
(0.0090 - 0.014)
<LOD 0.0092
(0.0068 - 0.012)
0.028
(0.020 - 0.035)
F
 
Table 14.5.2.2: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c91 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c91 footnotes

Table c91 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c91 footnote a referrer

Table c91 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c91 footnote b referrer

Total, 3-79 years
1Table c91 footnote b . . . . . . .
2 2535 37.24 0.012
(0.010 - 0.014)
<LOD 0.0094
(0.0084 - 0.010)
0.030
(0.025 - 0.036)
0.15E
(0.076 - 0.23)
3-5 years
1Table c91 footnote b . . . . . . .
2 522 35.25 0.014
(0.010 - 0.018)
<LOD F 0.031E
(0.017 - 0.044)
F
6-11 years
1 974 48.67 -- <LOD <LOD 0.019E
(0.011 - 0.028)
0.097
(0.064 - 0.13)
2 513 33.33 0.015
(0.012 - 0.021)
<LOD F 0.035
(0.024 - 0.045)
F
12-19 years
1 927 43.26 -- <LOD 0.0072E
(<LOD - 0.011)
0.020
(0.015 - 0.025)
0.085
(0.069 - 0.10)
2 507 34.12 0.014
(0.012 - 0.017)
<LOD F 0.034
(0.027 - 0.042)
0.19
(0.14 - 0.24)
20-39 years
1 1055 52.13 -- <LOD <LOD 0.017E
(<LOD - 0.028)
0.085E
(0.051 - 0.12)
2 355 39.44 0.012
(0.0086 - 0.016)
<LOD F 0.033
(0.025 - 0.042)
F
40-59 years
1 1109 54.19 -- <LOD <LOD 0.019
(0.013 - 0.025)
0.067
(0.056 - 0.077)
2 352 40.91 -- <LOD 0.0093
(0.0060 - 0.013)
0.027E
(0.012 - 0.042)
F
60-79 years
1 957 52.56 -- <LOD <LOD 0.019
(0.015 - 0.024)
0.071
(0.052 - 0.091)
2 286 46.15 -- <LOD 0.0089E
(<LOD - 0.013)
0.025
(0.022 - 0.028)
F
 
Table 14.5.2.3: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c92 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c92 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c92 footnotes

Table c92 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c92 footnote a referrer

Table c92 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c92 footnote b referrer

Table c92 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c92 footnote c referrer

Males, Total 3-79 years
1Table c92 footnote c . . . . . . .
2 1272 35.77 0.012
(0.010 - 0.015)
<LOD 0.0096
(0.0068 - 0.012)
0.033E
(0.021 - 0.045)
0.14E
(0.048 - 0.23)
Males, 6-11 years
1 501 50.70 -- <LOD <LOD 0.019E
(0.011 - 0.028)
0.074
(0.055 - 0.094)
2 261 34.10 0.016
(0.012 - 0.023)
<LOD F 0.036E
(0.015 - 0.057)
F
Males, 12-19 years
1 476 42.44 -- <LOD 0.0082
(<LOD - 0.011)
0.022
(0.018 - 0.026)
0.083
(0.067 - 0.098)
2 254 35.83 0.013
(0.0096 - 0.017)
<LOD F 0.031E
(0.017 - 0.045)
0.14E
(0.070 - 0.20)
Males, 20-39 years
1 463 50.97 -- <LOD <LOD F 0.056E
(0.023 - 0.090)
2 167 39.52 0.0093E
(0.0061 - 0.014)
<LOD F F X
Males, 40-59 years
1 513 52.05 -- <LOD <LOD 0.020
(0.015 - 0.025)
0.071
(0.052 - 0.089)
2 192 35.42 0.016E
(0.011 - 0.023)
<LOD 0.019E
(0.0087 - 0.030)
0.048E
(0.029 - 0.068)
X
Males, 60-79 years
1 480 51.88 -- <LOD <LOD 0.020
(0.018 - 0.022)
0.073
(0.049 - 0.097)
2 139 41.73 -- <LOD 0.0093E
(<LOD - 0.015)
0.027
(0.017 - 0.036)
X
Females, Total 3-79 years
1Table c92 footnote c . . . . . . .
2 1263 38.72 0.011
(0.0092 - 0.013)
<LOD 0.0092
(0.0069 - 0.011)
0.028
(0.021 - 0.036)
F
Females, 6-11 years
1 473 46.51 -- <LOD <LOD 0.019E
(0.0080 - 0.031)
0.11E
(0.065 - 0.16)
2 252 32.54 0.014E
(0.0098 - 0.021)
<LOD F 0.033E
(0.021 - 0.045)
F
Females, 12-19 years
1 451 44.12 -- <LOD 0.0061E
(<LOD - 0.011)
0.020E
(0.011 - 0.028)
0.086E
(0.052 - 0.12)
2 253 32.41 0.016
(0.011 - 0.021)
<LOD 0.019E
(0.0072 - 0.031)
0.037
(0.027 - 0.046)
0.23E
(0.13 - 0.33)
Females, 20-39 years
1 592 53.04 -- <LOD <LOD F 0.093E
(0.056 - 0.13)
2 188 39.36 0.014
(0.010 - 0.020)
<LOD 0.019E
(<LOD - 0.033)
0.034
(0.024 - 0.045)
X
Females, 40-59 years
1 596 56.04 -- <LOD <LOD F 0.062
(0.046 - 0.079)
2 160 47.50 -- <LOD <LOD 0.014E
(<LOD - 0.022)
X
Females, 60-79 years
1 477 53.25 -- <LOD <LOD 0.019E
(0.0095 - 0.029)
0.067
(0.046 - 0.087)
2 147 50.34 -- <LOD F 0.024
(0.019 - 0.028)
X
 
Table 14.5.2.4: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c93 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c93 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c93 footnotes

Table c93 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c93 footnote a referrer

Table c93 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c93 footnote b referrer

Total, 6-79 years
1 5008 50.50 -- <LOD <LOD 0.019
(0.016 - 0.022)
0.087
(0.066 - 0.11)
2 2004 37.92 0.011
(0.0096 - 0.013)
<LOD 0.011
(0.0086 - 0.013)
0.025
(0.020 - 0.029)
0.12E
(0.071 - 0.17)
Males, 6-79 years
1 2424 49.83 -- <LOD <LOD 0.016
(0.013 - 0.019)
0.070
(0.051 - 0.090)
2 1010 36.83 0.010
(0.0083 - 0.012)
<LOD 0.0095
(0.0073 - 0.012)
0.024
(0.017 - 0.030)
0.12E
(0.055 - 0.18)
Females, 6-79 years
1 2584 51.12 -- <LOD <LOD 0.024
(0.019 - 0.029)
0.096
(0.073 - 0.12)
2 994 39.03 0.013
(0.010 - 0.015)
<LOD 0.013
(0.0098 - 0.015)
0.026
(0.021 - 0.030)
0.14E
(0.059 - 0.22)
 
Table 14.5.2.5: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c94 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c94 footnotes

Table c94 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c94 footnote a referrer

Table c94 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c94 footnote b referrer

Total, 3-79 years
1Table c94 footnote b . . . . . . .
2 2525 37.39 0.012
(0.0099 - 0.014)
<LOD 0.011
(0.0088 - 0.013)
0.025
(0.021 - 0.030)
0.12E
(0.074 - 0.18)
3-5 years
1Table c94 footnote b . . . . . . .
2 521 35.32 0.024
(0.018 - 0.032)
<LOD 0.020E
(<LOD - 0.027)
0.052E
(0.026 - 0.078)
F
6-11 years
1 971 48.82 -- <LOD <LOD 0.025
(0.020 - 0.029)
0.13E
(0.073 - 0.19)
2 511 33.46 0.018
(0.013 - 0.024)
<LOD 0.016E
(<LOD - 0.022)
0.038E
(0.023 - 0.052)
F
12-19 years
1 925 43.35 -- <LOD 0.0077
(<LOD - 0.0088)
0.016
(0.014 - 0.018)
0.071
(0.050 - 0.092)
2 505 34.26 0.011
(0.0092 - 0.012)
<LOD 0.010
(<LOD - 0.012)
0.025
(0.020 - 0.029)
0.13
(0.092 - 0.16)
20-39 years
1 1051 52.33 -- <LOD <LOD 0.017
(<LOD - 0.021)
0.083E
(0.046 - 0.12)
2 353 39.66 0.0098
(0.0072 - 0.013)
<LOD 0.0093E
(<LOD - 0.013)
0.024
(0.016 - 0.032)
F
40-59 years
1 1104 54.44 -- <LOD <LOD 0.019
(0.016 - 0.023)
0.087
(0.058 - 0.12)
2 350 41.14 -- <LOD 0.011
(0.0079 - 0.014)
0.024
(0.016 - 0.031)
0.12E
(0.047 - 0.19)
60-79 years
1 957 52.56 -- <LOD <LOD 0.024
(0.017 - 0.031)
0.081
(0.061 - 0.10)
2 285 46.32 -- <LOD 0.013
(<LOD - 0.016)
0.025
(0.019 - 0.030)
0.18E
(0.079 - 0.28)
 
Table 14.5.2.6: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) (creatinine adjusted) - Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c95 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c95 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c95 footnotes

Table c95 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c95 footnote a referrer

Table c95 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c95 footnote b referrer

Table c95 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c95 footnote c referrer

Males, Total 3-79 years
1Table c95 footnote c . . . . . . .
2 1268 35.88 0.010
(0.0086 - 0.013)
<LOD 0.0098
(0.0076 - 0.012)
0.025
(0.018 - 0.031)
0.12E
(0.050 - 0.19)
Males, 6-11 years
1 499 50.90 -- <LOD <LOD 0.024
(0.017 - 0.031)
F
2 260 34.23 0.019
(0.013 - 0.027)
<LOD 0.014E
(<LOD - 0.021)
0.045E
(0.024 - 0.065)
F
Males, 12-19 years
1 475 42.53 -- <LOD 0.0073
(<LOD - 0.0083)
0.016
(0.013 - 0.019)
0.087
(0.058 - 0.12)
2 253 35.97 0.0091
(0.0068 - 0.012)
<LOD 0.0086E
(<LOD - 0.012)
0.026E
(0.017 - 0.036)
0.090
(0.063 - 0.12)
Males, 20-39 years
1 461 51.19 -- <LOD <LOD 0.013
(<LOD - 0.016)
0.055E
(0.024 - 0.087)
2 166 39.76 0.0065E
(0.0043 - 0.0097)
<LOD <LOD
(<LOD - 0.0088)
F X
Males, 40-59 years
1 509 52.46 -- <LOD <LOD 0.016
(0.012 - 0.021)
0.067E
(0.032 - 0.10)
2 192 35.42 0.013
(0.0095 - 0.019)
<LOD 0.014E
(0.0084 - 0.020)
0.027E
(0.010 - 0.044)
X
Males, 60-79 years
1 480 51.88 -- <LOD <LOD 0.018
(0.013 - 0.023)
0.067
(0.050 - 0.084)
2 139 41.73 -- <LOD 0.0091E
(<LOD - 0.014)
0.022E
(0.013 - 0.032)
X
Females, Total 3-79 years
1Table c95 footnote c . . . . . . .
2 1257 38.90 0.013
(0.011 - 0.015)
<LOD 0.013
(0.010 - 0.015)
0.026
(0.021 - 0.030)
0.15E
(0.072 - 0.22)
Females, 6-11 years
1 472 46.61 -- <LOD <LOD 0.025
(0.019 - 0.031)
0.14E
(0.055 - 0.23)
2 251 32.67 0.017E
(0.011 - 0.025)
<LOD 0.017
(<LOD - 0.022)
0.031E
(0.018 - 0.045)
F
Females, 12-19 years
1 450 44.22 -- <LOD 0.0080
(<LOD - 0.0095)
0.016
(0.014 - 0.019)
0.058
(0.043 - 0.074)
2 252 32.54 0.013
(0.010 - 0.016)
<LOD 0.012
(0.0076 - 0.016)
0.024
(0.019 - 0.029)
0.15E
(0.082 - 0.22)
Females, 20-39 years
1 590 53.22 -- <LOD <LOD 0.024E
(<LOD - 0.034)
0.099E
(0.060 - 0.14)
2 187 39.57 0.014
(0.011 - 0.020)
<LOD 0.015E
(<LOD - 0.022)
0.028E
(0.014 - 0.042)
X
Females, 40-59 years
1 595 56.13 -- <LOD <LOD 0.025
(<LOD - 0.031)
0.092
(0.066 - 0.12)
2 158 48.10 -- <LOD <LOD 0.019E
(<LOD - 0.027)
X
Females, 60-79 years
1 477 53.25 -- <LOD <LOD 0.031
(0.021 - 0.041)
0.094
(0.068 - 0.12)
2 146 50.68 -- <LOD <LOD
(<LOD - 0.018)
0.026
(0.017 - 0.035)
X
 
Table 14.5.3.1: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) - Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years Table c96 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c96 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c96 footnotes

Table c96 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c96 footnote a referrer

Table c96 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c96 footnote b referrer

Total, 6-79 years
1 5431 1.57 0.085
(0.070 - 0.10)
0.018
(0.014 - 0.023)
0.071
(0.057 - 0.086)
0.17
(0.13 - 0.21)
0.94
(0.72 - 1.2)
2 2033 0.74 0.13
(0.10 - 0.16)
0.025
(0.021 - 0.028)
0.096
(0.078 - 0.11)
0.29E
(0.18 - 0.39)
2.2E
(0.68 - 3.8)
Males, 6-79 years
1 2636 1.37 0.090
(0.073 - 0.11)
0.020
(0.015 - 0.025)
0.072
(0.057 - 0.088)
0.18
(0.13 - 0.22)
1.1
(0.78 - 1.4)
2 1019 0.88 0.11
(0.088 - 0.13)
0.024
(0.019 - 0.030)
0.089
(0.068 - 0.11)
0.23E
(0.15 - 0.31)
1.3E
(0.39 - 2.1)
Females, 6-79 years
1 2795 1.75 0.080
(0.066 - 0.098)
0.017
(0.012 - 0.021)
0.071
(0.055 - 0.086)
0.17
(0.13 - 0.21)
0.79
(0.63 - 0.95)
2 1014 0.59 0.15
(0.11 - 0.20)
0.026
(0.020 - 0.031)
0.10
(0.074 - 0.13)
0.36E
(0.19 - 0.53)
F
 
Table 14.5.3.2: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c97 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c97 footnotes

Table c97 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c97 footnote a referrer

Table c97 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c97 footnote b referrer

Total, 3-79 years
1Table c97 footnote b . . . . . . .
2 2553 0.86 0.12
(0.10 - 0.15)
0.024
(0.021 - 0.028)
0.093
(0.076 - 0.11)
0.27E
(0.17 - 0.37)
2.2E
(0.78 - 3.6)
3-5 years
1Table c97 footnote b . . . . . . .
2 520 1.35 0.067
(0.049 - 0.091)
0.016
(0.011 - 0.022)
0.065
(0.047 - 0.082)
0.12
(0.078 - 0.15)
F
6-11 years
1 1026 2.73 0.054
(0.043 - 0.067)
0.014
(0.0099 - 0.018)
0.049
(0.038 - 0.060)
0.099
(0.087 - 0.11)
0.38E
(0.18 - 0.57)
2 514 1.17 0.069
(0.059 - 0.082)
0.018
(0.014 - 0.022)
0.056
(0.046 - 0.065)
0.11
(0.082 - 0.14)
F
12-19 years
1 970 0.82 0.090
(0.067 - 0.12)
0.019
(0.013 - 0.025)
0.077
(0.055 - 0.099)
0.18
(0.13 - 0.24)
1.0E
(0.44 - 1.6)
2 510 0.39 0.10
(0.082 - 0.13)
0.026
(0.022 - 0.030)
0.080
(0.065 - 0.095)
0.18E
(0.10 - 0.27)
1.7E
(0.90 - 2.4)
20-39 years
1 1151 1.13 0.086
(0.070 - 0.11)
0.020
(0.015 - 0.024)
0.076
(0.057 - 0.094)
0.15
(0.12 - 0.19)
0.75E
(0.35 - 1.1)
2 359 0.28 0.18E
(0.12 - 0.29)
0.027
(0.019 - 0.035)
0.13
(0.092 - 0.17)
0.37E
(0.13 - 0.61)
F
40-59 years
1 1208 2.15 0.092
(0.073 - 0.12)
0.018
(0.012 - 0.024)
0.077
(0.054 - 0.099)
0.21
(0.16 - 0.26)
1.2
(0.91 - 1.5)
2 359 1.11 0.12
(0.089 - 0.17)
0.024
(0.016 - 0.031)
0.10E
(0.054 - 0.15)
0.32
(0.20 - 0.43)
1.6E
(0.46 - 2.7)
60-79 years
1 1076 0.93 0.083
(0.066 - 0.10)
0.019
(0.015 - 0.024)
0.067
(0.050 - 0.083)
0.16E
(0.094 - 0.23)
0.75
(0.47 - 1.0)
2 291 0.69 0.11E
(0.072 - 0.16)
0.021
(0.014 - 0.029)
0.086
(0.064 - 0.11)
F F
 
Table 14.5.3.3: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c98 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c98 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c98 footnotes

Table c98 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c98 footnote a referrer

Table c98 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c98 footnote b referrer

Table c98 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c98 footnote c referrer

Males, Total 3-79 years
1Table c98 footnote c . . . . . . .
2 1277 1.10 0.10
(0.086 - 0.13)
0.024
(0.018 - 0.029)
0.088
(0.068 - 0.11)
0.22E
(0.14 - 0.31)
1.2E
(0.39 - 2.1)
Males, 6-11 years
1 524 2.48 0.052
(0.039 - 0.070)
0.013E
(<LOD - 0.021)
0.046
(0.035 - 0.056)
0.092
(0.078 - 0.11)
F
2 260 0.77 0.071
(0.054 - 0.093)
0.019
(0.014 - 0.024)
0.055
(0.045 - 0.065)
0.11E
(0.034 - 0.19)
F
Males, 12-19 years
1 498 0.20 0.082
(0.062 - 0.11)
0.020
(0.017 - 0.024)
0.069
(0.051 - 0.087)
0.14E
(0.076 - 0.20)
0.97E
(0.40 - 1.5)
2 255 0.39 0.089
(0.071 - 0.11)
0.026
(0.022 - 0.030)
0.073
(0.059 - 0.088)
0.14E
(0.074 - 0.20)
0.95E
(0.27 - 1.6)
Males, 20-39 years
1 506 1.78 0.089
(0.069 - 0.11)
0.020
(0.014 - 0.026)
0.075
(0.054 - 0.096)
0.16E
(0.10 - 0.22)
F
2 168 0.60 0.11E
(0.073 - 0.16)
0.027E
(0.017 - 0.036)
0.11
(0.085 - 0.14)
F X
Males, 40-59 years
1 569 1.76 0.10
(0.080 - 0.14)
0.021
(0.014 - 0.027)
0.081
(0.056 - 0.11)
0.23E
(0.14 - 0.33)
1.3E
(0.42 - 2.2)
2 194 2.06 0.12E
(0.084 - 0.18)
0.021E
(0.010 - 0.032)
0.10E
(0.035 - 0.17)
0.31E
(0.19 - 0.43)
X
Males, 60-79 years
1 539 0.56 0.091
(0.071 - 0.12)
0.026
(0.019 - 0.032)
0.076
(0.051 - 0.10)
0.18E
(0.11 - 0.24)
0.71
(0.50 - 0.93)
2 142 0.70 0.10E
(0.067 - 0.16)
0.025E
(0.016 - 0.033)
0.081E
(0.051 - 0.11)
0.19E
(0.069 - 0.31)
X
Females, Total 3-79 years
1Table c98 footnote c . . . . . . .
2 1276 0.63 0.15
(0.11 - 0.20)
0.025
(0.020 - 0.030)
0.099
(0.077 - 0.12)
0.36E
(0.20 - 0.52)
F
Females, 6-11 years
1 502 2.99 0.055
(0.045 - 0.068)
0.015
(0.012 - 0.017)
0.054
(0.039 - 0.069)
0.11
(0.088 - 0.14)
0.41E
(0.22 - 0.59)
2 254 1.57 0.068
(0.054 - 0.084)
0.016
(0.010 - 0.022)
0.057
(0.039 - 0.076)
0.11
(0.076 - 0.15)
F
Females, 12-19 years
1 472 1.48 0.10E
(0.070 - 0.15)
0.017E
(<LOD - 0.028)
0.086
(0.054 - 0.12)
0.22E
(0.13 - 0.30)
F
2 255 0.39 0.12
(0.086 - 0.18)
0.026
(0.017 - 0.035)
0.093
(0.073 - 0.11)
F 1.8E
(0.82 - 2.8)
Females, 20-39 years
1 645 0.62 0.084
(0.068 - 0.10)
0.020
(0.015 - 0.025)
0.078
(0.059 - 0.097)
0.15
(0.11 - 0.18)
0.68
(0.46 - 0.90)
2 191 0 0.30E
(0.15 - 0.61)
0.027E
(0.0088 - 0.045)
F F X
Females, 40-59 years
1 639 2.50 0.080
(0.063 - 0.10)
0.014E
(0.0070 - 0.021)
0.072E
(0.045 - 0.099)
0.19
(0.14 - 0.24)
0.79
(0.55 - 1.0)
2 165 0 0.12E
(0.078 - 0.19)
0.027E
(0.015 - 0.039)
0.099E
(0.042 - 0.16)
0.33E
(0.15 - 0.52)
X
Females, 60-79 years
1 537 1.30 0.076
(0.059 - 0.098)
0.017
(0.014 - 0.021)
0.061
(0.044 - 0.077)
0.14E
(0.064 - 0.22)
0.86E
(0.44 - 1.3)
2 149 0.67 0.11E
(0.068 - 0.18)
0.019E
(0.010 - 0.027)
F F X
 
Table 14.5.3.4: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c99 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c99 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c99 footnotes

Table c99 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c99 footnote a referrer

Table c99 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c99 footnote b referrer

Total, 6-79 years
1 5417 1.57 0.10
(0.087 - 0.12)
0.027
(0.024 - 0.031)
0.086
(0.072 - 0.099)
0.18
(0.13 - 0.22)
1.1
(0.84 - 1.3)
2 2024 0.74 0.12
(0.10 - 0.15)
0.029
(0.026 - 0.032)
0.088
(0.071 - 0.10)
0.23
(0.17 - 0.28)
F
Males, 6-79 years
1 2627 1.37 0.089
(0.074 - 0.11)
0.024
(0.021 - 0.026)
0.071
(0.059 - 0.083)
0.15
(0.11 - 0.20)
0.99
(0.66 - 1.3)
2 1016 0.89 0.087
(0.075 - 0.10)
0.026
(0.023 - 0.029)
0.069
(0.054 - 0.084)
0.15
(0.12 - 0.18)
0.96E
(0.42 - 1.5)
Females, 6-79 years
1 2790 1.76 0.12
(0.10 - 0.14)
0.033
(0.028 - 0.038)
0.099
(0.085 - 0.11)
0.20
(0.13 - 0.26)
1.2
(0.96 - 1.4)
2 1008 0.60 0.17
(0.13 - 0.22)
0.034
(0.029 - 0.040)
0.11
(0.079 - 0.14)
0.33E
(0.19 - 0.48)
F
 
Table 14.5.3.5: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c100 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c100 footnotes

Table c100 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c100 footnote a referrer

Table c100 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c100 footnote b referrer

Total, 3-79 years
1Table c100 footnote b . . . . . . .
2 2543 0.87 0.12
(0.10 - 0.15)
0.029
(0.026 - 0.032)
0.088
(0.071 - 0.10)
0.23
(0.17 - 0.28)
F
3-5 years
1Table c100 footnote b . . . . . . .
2 519 1.35 0.11
(0.084 - 0.16)
0.031
(0.022 - 0.039)
0.091
(0.064 - 0.12)
0.18E
(0.10 - 0.26)
F
6-11 years
1 1023 2.74 0.083
(0.070 - 0.098)
0.028
(0.022 - 0.033)
0.071
(0.063 - 0.079)
0.13
(0.094 - 0.17)
0.58E
(0.21 - 0.95)
2 512 1.17 0.080
(0.068 - 0.094)
0.027
(0.023 - 0.031)
0.059
(0.052 - 0.066)
0.13
(0.098 - 0.16)
0.71E
(<LOD - 1.2)
12-19 years
1 968 0.83 0.079
(0.062 - 0.10)
0.022
(0.020 - 0.024)
0.061
(0.043 - 0.080)
0.14
(0.10 - 0.18)
0.98E
(0.55 - 1.4)
2 508 0.39 0.079
(0.063 - 0.10)
0.024
(0.020 - 0.027)
0.061
(0.047 - 0.074)
0.12E
(0.055 - 0.19)
0.88E
(0.53 - 1.2)
20-39 years
1 1147 1.13 0.096
(0.080 - 0.12)
0.026
(0.021 - 0.031)
0.084
(0.069 - 0.099)
0.16
(0.13 - 0.20)
0.82E
(0.40 - 1.2)
2 357 0.28 0.16E
(0.10 - 0.23)
0.029
(0.025 - 0.034)
0.10
(0.072 - 0.13)
0.26E
(0.084 - 0.44)
F
40-59 years
1 1203 2.16 0.12
(0.097 - 0.14)
0.029
(0.023 - 0.035)
0.097
(0.079 - 0.11)
0.23
(0.15 - 0.31)
1.2
(0.97 - 1.5)
2 357 1.12 0.12
(0.10 - 0.15)
0.032
(0.023 - 0.041)
0.084E
(0.046 - 0.12)
0.23
(0.18 - 0.29)
1.3E
(0.50 - 2.1)
60-79 years
1 1076 0.93 0.12
(0.093 - 0.14)
0.034
(0.031 - 0.037)
0.093
(0.073 - 0.11)
0.20E
(0.12 - 0.28)
1.2E
(0.61 - 1.7)
2 290 0.69 0.13E
(0.083 - 0.19)
0.030
(0.020 - 0.041)
0.096
(0.067 - 0.12)
0.23E
(<LOD - 0.37)
F
 
Table 14.5.3.6: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c101 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c101 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c101 footnotes

Table c101 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c101 footnote a referrer

Table c101 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c101 footnote b referrer

Table c101 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c101 footnote c referrer

Males, Total 3-79 years
1Table c101 footnote c . . . . . . .
2 1273 1.10 0.088
(0.075 - 0.10)
0.026
(0.023 - 0.029)
0.069
(0.054 - 0.084)
0.15
(0.12 - 0.18)
0.96E
(0.44 - 1.5)
Males, 6-11 years
1 522 2.49 0.079
(0.065 - 0.095)
0.027
(<LOD - 0.032)
0.068
(0.062 - 0.074)
0.11
(0.078 - 0.15)
F
2 259 0.77 0.081
(0.064 - 0.10)
0.027
(0.020 - 0.034)
0.059
(0.052 - 0.066)
0.12E
(0.057 - 0.19)
F
Males, 12-19 years
1 497 0.20 0.070
(0.053 - 0.092)
0.022
(0.019 - 0.024)
0.052
(0.036 - 0.069)
0.12E
(0.075 - 0.17)
0.71E
(0.25 - 1.2)
2 254 0.39 0.063
(0.050 - 0.079)
0.020
(0.017 - 0.023)
0.051
(0.041 - 0.061)
0.092E
(0.054 - 0.13)
0.76E
(0.25 - 1.3)
Males, 20-39 years
1 504 1.79 0.082
(0.065 - 0.10)
0.022
(0.019 - 0.026)
0.067
(0.054 - 0.081)
0.14
(0.090 - 0.18)
F
2 167 0.60 0.077
(0.055 - 0.11)
0.027
(0.021 - 0.033)
0.068
(0.045 - 0.090)
0.13
(0.098 - 0.17)
X
Males, 40-59 years
1 565 1.77 0.10
(0.082 - 0.13)
0.024
(0.019 - 0.029)
0.081
(0.061 - 0.10)
0.21E
(0.12 - 0.29)
1.3E
(0.60 - 2.0)
2 194 2.06 0.11
(0.083 - 0.13)
0.027
(0.018 - 0.035)
0.076E
(0.040 - 0.11)
0.20
(0.15 - 0.25)
X
Males, 60-79 years
1 539 0.56 0.096
(0.080 - 0.11)
0.029
(0.023 - 0.035)
0.074
(0.054 - 0.094)
0.16
(0.11 - 0.22)
0.67E
(0.31 - 1.0)
2 142 0.70 0.098E
(0.067 - 0.14)
0.024E
(0.0092 - 0.039)
0.082E
(0.052 - 0.11)
0.16E
(0.086 - 0.24)
X
Females, Total 3-79 years
1Table c101 footnote c . . . . . . .
2 1270 0.63 0.17
(0.13 - 0.22)
0.035
(0.029 - 0.040)
0.11
(0.080 - 0.14)
0.33E
(0.19 - 0.46)
F
Females, 6-11 years
1 501 2.99 0.087
(0.071 - 0.11)
0.028
(0.021 - 0.035)
0.077
(0.058 - 0.096)
0.15
(0.11 - 0.19)
0.54
(0.34 - 0.73)
2 253 1.58 0.080
(0.064 - 0.10)
0.025
(0.019 - 0.031)
0.064
(0.050 - 0.078)
0.13E
(0.083 - 0.18)
F
Females, 12-19 years
1 471 1.49 0.091
(0.071 - 0.12)
0.023
(<LOD - 0.028)
0.073
(0.052 - 0.095)
0.17
(0.12 - 0.21)
1.6E
(0.47 - 2.8)
2 254 0.39 0.10
(0.076 - 0.13)
0.030
(0.023 - 0.037)
0.073
(0.059 - 0.087)
F 1.1E
(0.41 - 1.8)
Females, 20-39 years
1 643 0.62 0.11
(0.093 - 0.14)
0.032
(0.025 - 0.039)
0.099
(0.080 - 0.12)
0.18
(0.13 - 0.23)
0.78E
(0.41 - 1.2)
2 190 0 0.31E
(0.16 - 0.59)
0.040E
(0.020 - 0.061)
F F X
Females, 40-59 years
1 638 2.51 0.13
(0.11 - 0.16)
0.040
(0.034 - 0.045)
0.10
(0.087 - 0.12)
0.24E
(0.13 - 0.36)
1.2
(0.98 - 1.4)
2 163 0 0.14
(0.11 - 0.20)
0.042
(0.027 - 0.057)
0.11E
(0.050 - 0.17)
0.26E
(0.12 - 0.40)
X
Females, 60-79 years
1 537 1.30 0.14
(0.10 - 0.18)
0.036
(0.027 - 0.045)
0.11
(0.079 - 0.14)
0.24E
(0.11 - 0.38)
1.5E
(0.81 - 2.2)
2 148 0.68 0.16E
(0.087 - 0.28)
0.034E
(0.021 - 0.046)
0.11E
(0.059 - 0.17)
0.30E
(<LOD - 0.48)
X
 
Table 14.5.4.1: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years Table c102 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c102 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c102 footnotes

Table c102 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c102 footnote a referrer

Table c102 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c102 footnote b referrer

Total, 6-79 years
1 5457 0.40 0.20
(0.17 - 0.24)
0.040
(0.032 - 0.049)
0.17
(0.14 - 0.20)
0.43
(0.33 - 0.53)
2.5
(1.9 - 3.1)
2 2037 0.39 0.29
(0.23 - 0.37)
0.051
(0.043 - 0.059)
0.22
(0.17 - 0.26)
0.68
(0.45 - 0.91)
6.8E
(1.9 - 12)
Males, 6-79 years
1 2650 0.30 0.22
(0.18 - 0.26)
0.046
(0.036 - 0.055)
0.18
(0.15 - 0.20)
0.44
(0.31 - 0.57)
2.8E
(1.4 - 4.2)
2 1021 0.39 0.25
(0.20 - 0.31)
0.048
(0.035 - 0.061)
0.21
(0.17 - 0.25)
0.55E
(0.30 - 0.81)
F
Females, 6-79 years
1 2807 0.50 0.19
(0.16 - 0.22)
0.036
(0.028 - 0.043)
0.16
(0.13 - 0.20)
0.41
(0.32 - 0.51)
2.1
(1.5 - 2.7)
2 1016 0.39 0.34
(0.25 - 0.47)
0.052
(0.039 - 0.065)
0.22
(0.16 - 0.29)
0.77E
(0.33 - 1.2)
F
 
Table 14.5.4.2: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c103 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c103 footnotes

Table c103 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c103 footnote a referrer

Table c103 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c103 footnote b referrer

Total, 3-79 years
1Table c103 footnote b . . . . . . .
2 2558 0.35 0.29
(0.23 - 0.37)
0.051
(0.043 - 0.059)
0.22
(0.17 - 0.26)
0.67
(0.45 - 0.90)
6.8E
(2.1 - 11)
3-5 years
1Table c103 footnote b . . . . . . .
2 521 0.19 0.22
(0.16 - 0.31)
0.055
(0.038 - 0.071)
0.19
(0.13 - 0.25)
0.40E
(0.22 - 0.59)
F
6-11 years
1 1027 0.29 0.17
(0.15 - 0.21)
0.041E
(0.025 - 0.057)
0.15
(0.12 - 0.18)
0.34
(0.27 - 0.41)
1.4
(1.1 - 1.8)
2 516 0.78 0.21
(0.18 - 0.25)
0.048
(0.037 - 0.059)
0.17
(0.15 - 0.19)
0.37
(0.24 - 0.50)
F
12-19 years
1 978 0.10 0.24
(0.18 - 0.33)
0.048E
(0.030 - 0.066)
0.20
(0.16 - 0.24)
0.49E
(0.27 - 0.70)
3.8E
(2.0 - 5.6)
2 511 0 0.27
(0.21 - 0.34)
0.057
(0.048 - 0.067)
0.20
(0.16 - 0.25)
0.50E
(0.23 - 0.77)
4.8E
(2.1 - 7.5)
20-39 years
1 1158 0.60 0.20
(0.16 - 0.24)
0.042
(0.031 - 0.053)
0.17
(0.14 - 0.21)
0.40
(0.30 - 0.49)
2.0E
(1.1 - 2.8)
2 359 0 0.41E
(0.25 - 0.66)
0.061
(0.040 - 0.082)
0.28E
(0.12 - 0.43)
0.79E
(0.35 - 1.2)
F
40-59 years
1 1216 0.58 0.21
(0.17 - 0.26)
0.037
(0.029 - 0.044)
0.18
(0.13 - 0.22)
0.51
(0.33 - 0.69)
3.2E
(1.9 - 4.5)
2 360 0.56 0.27
(0.20 - 0.35)
0.041E
(0.022 - 0.060)
0.22
(0.15 - 0.30)
0.69E
(0.41 - 0.96)
F
60-79 years
1 1078 0.37 0.18
(0.15 - 0.22)
0.040
(0.032 - 0.047)
0.15
(0.12 - 0.18)
0.35E
(0.21 - 0.49)
1.9E
(1.1 - 2.6)
2 291 0.69 0.23E
(0.14 - 0.39)
0.041E
(0.026 - 0.056)
0.17E
(0.082 - 0.25)
F F
 
Table 14.5.4.3: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group Table c104 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c104 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c104 footnotes

Table c104 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c104 footnote a referrer

Table c104 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c104 footnote b referrer

Table c104 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c104 footnote c referrer

Males, Total 3-79 years
1Table c104 footnote c . . . . . . .
2 1279 0.31 0.25
(0.20 - 0.31)
0.048
(0.036 - 0.060)
0.21
(0.17 - 0.25)
0.55E
(0.31 - 0.80)
F
Males, 6-11 years
1 524 0.19 0.17
(0.13 - 0.22)
0.040E
(0.017 - 0.064)
0.14
(0.11 - 0.17)
0.30
(0.24 - 0.36)
1.5E
(0.81 - 2.1)
2 262 0.76 0.21
(0.16 - 0.28)
0.047E
(0.028 - 0.066)
0.18
(0.15 - 0.22)
0.39E
(0.13 - 0.65)
F
Males, 12-19 years
1 501 0 0.22
(0.17 - 0.30)
0.049
(0.033 - 0.064)
0.19
(0.15 - 0.22)
0.43E
(0.24 - 0.62)
2.4E
(0.75 - 4.0)
2 255 0 0.24
(0.18 - 0.30)
0.058
(0.048 - 0.067)
0.18
(0.13 - 0.23)
0.42E
(0.26 - 0.59)
F
Males, 20-39 years
1 510 0.78 0.21
(0.16 - 0.26)
0.045
(0.033 - 0.057)
0.17
(0.13 - 0.21)
0.41E
(0.25 - 0.57)
F
2 168 0 0.27E
(0.18 - 0.39)
0.060E
(0.029 - 0.091)
0.25E
(0.15 - 0.36)
0.53E
(0.18 - 0.88)
X
Males, 40-59 years
1 576 0.35 0.25
(0.19 - 0.33)
0.043
(0.031 - 0.056)
0.20
(0.15 - 0.25)
0.60E
(0.35 - 0.84)
F
2 194 1.03 0.27E
(0.18 - 0.40)
0.038E
(0.016 - 0.060)
0.21E
(0.085 - 0.34)
0.76E
(0.37 - 1.1)
X
Males, 60-79 years
1 539 0.19 0.20
(0.16 - 0.25)
0.052
(0.044 - 0.060)
0.17
(0.13 - 0.21)
0.39
(0.26 - 0.52)
1.7E
(1.1 - 2.3)
2 142 0 0.22E
(0.13 - 0.38)
0.041E
(0.024 - 0.059)
0.17E
(0.074 - 0.26)
F X
Females, Total 3-79 years
1Table c104 footnote c . . . . . . .
2 1279 0.39 0.34
(0.24 - 0.46)
0.052
(0.040 - 0.064)
0.22
(0.16 - 0.28)
0.74E
(0.33 - 1.1)
F
Females, 6-11 years
1 503 0.40 0.18
(0.15 - 0.22)
0.042
(0.029 - 0.056)
0.16
(0.12 - 0.21)
0.38
(0.28 - 0.49)
1.4
(0.98 - 1.9)
2 254 0.79 0.21
(0.16 - 0.26)
0.048
(0.036 - 0.060)
0.16
(0.12 - 0.20)
0.37E
(0.21 - 0.53)
F
Females, 12-19 years
1 477 0.21 0.27
(0.19 - 0.37)
0.045E
(0.023 - 0.067)
0.21
(0.16 - 0.26)
0.66E
(0.36 - 0.96)
F
2 256 0 0.31
(0.22 - 0.44)
0.057E
(0.032 - 0.083)
0.25
(0.17 - 0.32)
F 5.9E
(2.9 - 9.0)
Females, 20-39 years
1 648 0.46 0.19
(0.16 - 0.23)
0.037
(0.025 - 0.050)
0.17
(0.13 - 0.22)
0.37
(0.29 - 0.46)
1.7E
(1.1 - 2.4)
2 191 0 F 0.065E
(0.035 - 0.095)
F F X
Females, 40-59 years
1 640 0.78 0.18
(0.15 - 0.23)
0.033
(0.025 - 0.041)
0.16E
(0.099 - 0.22)
0.45E
(0.27 - 0.63)
2.2
(1.4 - 2.9)
2 166 0 0.27E
(0.17 - 0.42)
0.047E
(0.018 - 0.077)
0.22E
(0.13 - 0.32)
0.60E
(0.19 - 1.0)
X
Females, 60-79 years
1 539 0.56 0.16
(0.13 - 0.21)
0.034
(0.026 - 0.042)
0.12
(0.090 - 0.16)
0.30E
(0.11 - 0.50)
2.0E
(0.92 - 3.1)
2 149 1.34 0.24E
(0.13 - 0.45)
0.039E
(0.023 - 0.056)
F F X
 
Table 14.5.4.4: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years Table c105 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c105 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c105 footnotes

Table c105 footnote 1

For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c105 footnote a referrer

Table c105 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c105 footnote b referrer

Total, 6-79 years
1 5443 0.40 0.25
(0.21 - 0.29)
0.062
(0.057 - 0.067)
0.19
(0.16 - 0.22)
0.46
(0.35 - 0.56)
3.0
(2.3 - 3.7)
2 2028 0.39 0.28
(0.23 - 0.35)
0.062
(0.054 - 0.069)
0.20
(0.15 - 0.24)
0.56
(0.42 - 0.70)
F
Males, 6-79 years
1 2641 0.30 0.22
(0.18 - 0.26)
0.056
(0.049 - 0.063)
0.17
(0.14 - 0.19)
0.39
(0.28 - 0.50)
2.6E
(1.7 - 3.6)
2 1018 0.39 0.21
(0.17 - 0.25)
0.054
(0.044 - 0.064)
0.17
(0.13 - 0.21)
0.36
(0.25 - 0.47)
F
Females, 6-79 years
1 2802 0.50 0.28
(0.24 - 0.32)
0.068
(0.060 - 0.076)
0.22
(0.17 - 0.26)
0.51
(0.37 - 0.65)
3.3
(2.8 - 3.9)
2 1010 0.40 0.38
(0.28 - 0.52)
0.070
(0.058 - 0.083)
0.24
(0.18 - 0.31)
0.93E
(0.52 - 1.3)
F
 
Table 14.5.4.5: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c106 footnote a GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c106 footnotes

Table c106 footnote 1

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c106 footnote a referrer

Table c106 footnote 2

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c106 footnote b referrer

Total, 3-79 years
1Table c106 footnote b . . . . . . .
2 2548 0.35 0.28
(0.23 - 0.35)
0.063
(0.055 - 0.070)
0.20
(0.15 - 0.24)
0.57
(0.43 - 0.71)
F
3-5 years
1Table c106 footnote b . . . . . . .
2 520 0.19 0.39
(0.27 - 0.55)
0.097
(0.063 - 0.13)
0.32
(0.22 - 0.42)
0.78E
(0.48 - 1.1)
F
6-11 years
1 1024 0.29 0.27
(0.24 - 0.31)
0.086
(0.078 - 0.095)
0.21
(0.18 - 0.24)
0.46
(0.37 - 0.54)
2.4E
(1.3 - 3.6)
2 514 0.78 0.24
(0.21 - 0.29)
0.077
(0.068 - 0.087)
0.18
(0.16 - 0.21)
0.43
(0.30 - 0.55)
F
12-19 years
1 976 0.10 0.21
(0.17 - 0.27)
0.056
(0.047 - 0.065)
0.15
(0.11 - 0.20)
0.42E
(0.25 - 0.60)
2.4E
(1.2 - 3.5)
2 509 0 0.21
(0.16 - 0.26)
0.057
(0.049 - 0.065)
0.16
(0.12 - 0.19)
0.32E
(0.092 - 0.54)
2.4E
(1.3 - 3.5)
20-39 years
1 1154 0.61 0.22
(0.19 - 0.26)
0.058
(0.050 - 0.067)
0.17
(0.14 - 0.21)
0.40
(0.31 - 0.49)
2.3E
(1.4 - 3.3)
2 357 0 0.35E
(0.23 - 0.54)
0.059
(0.039 - 0.079)
0.22E
(0.13 - 0.30)
0.58E
(0.28 - 0.89)
F
40-59 years
1 1211 0.58 0.27
(0.23 - 0.33)
0.063
(0.057 - 0.069)
0.20
(0.17 - 0.23)
0.50E
(0.30 - 0.70)
3.6
(2.9 - 4.4)
2 358 0.56 0.27
(0.23 - 0.32)
0.065
(0.051 - 0.079)
0.20E
(0.12 - 0.27)
0.60
(0.43 - 0.76)
F
60-79 years
1 1078 0.37 0.25
(0.21 - 0.31)
0.066
(0.060 - 0.072)
0.20
(0.16 - 0.25)
0.48E
(0.29 - 0.66)
2.9E
(1.7 - 4.2)
2 290 0.69 0.27E
(0.16 - 0.45)
0.052
(0.036 - 0.069)
0.19E
(0.10 - 0.27)
F F
 
Table 14.5.4.6: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) (creatinine adjusted) - Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group Table c107 footnote a, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle N %<LODTable c107 footnote b GM
(95% CI)
10th
(95% CI)
50th
(95% CI)
75th
(95% CI)
95th
(95% CI)

Table c107 footnotes

Table c107 footnote 1

Breakdown by sex for the 3-5 year old age group is not recommended.

Return to table c107 footnote a referrer

Table c107 footnote 2

If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated.

Return to table c107 footnote b referrer

Table c107 footnote 3

Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009).

Return to table c107 footnote c referrer

Males, Total 3-79 years
1Table c107 footnote c . . . . . . .
2 1275 0.31 0.21
(0.18 - 0.25)
0.055
(0.045 - 0.065)
0.17
(0.13 - 0.21)
0.38
(0.27 - 0.49)
F
Males, 6-11 years
1 522 0.19 0.26
(0.22 - 0.30)
0.083
(0.073 - 0.092)
0.20
(0.17 - 0.23)
0.39
(0.30 - 0.49)
2.5E
(0.76 - 4.3)
2 261 0.77 0.24
(0.20 - 0.30)
0.082
(0.065 - 0.098)
0.19
(0.16 - 0.21)
0.46E
(0.25 - 0.66)
F
Males, 12-19 years
1 500 0 0.19
(0.14 - 0.25)
0.054
(0.045 - 0.063)
0.15
(0.11 - 0.19)
0.38E
(0.19 - 0.58)
1.8E
(0.90 - 2.7)
2 254 0 0.17
(0.13 - 0.21)
0.054
(0.046 - 0.063)
0.13
(0.097 - 0.16)
0.24E
(0.13 - 0.34)
1.8E
(<LOD - 3.0)
Males, 20-39 years
1 508 0.79 0.19
(0.16 - 0.24)
0.053
(0.039 - 0.067)
0.14
(0.11 - 0.17)
0.32
(0.22 - 0.43)
2.5E
(<LOD - 4.3)
2 167 0 0.19
(0.14 - 0.25)
0.059
(0.042 - 0.076)
0.17
(0.12 - 0.22)
0.32
(0.23 - 0.42)
X
Males, 40-59 years
1 572 0.35 0.25
(0.19 - 0.31)
0.056
(0.044 - 0.069)
0.19
(0.16 - 0.22)
0.49E
(0.29 - 0.69)
3.9E
(2.0 - 5.8)
2 194